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Abstract Ceramides are central intermediates of sphingolipid metabolism that also function as
potent messengers in stress signaling and apoptosis. Progress in understanding how ceramides
execute their biological roles is hampered by a lack of methods to manipulate their cellular levels
and metabolic fate with appropriate spatiotemporal precision. Here, we report on clickable,
azobenzene-containing ceramides, caCers, as photoswitchable metabolic substrates to exert
optical control over sphingolipid production in cells. Combining atomic force microscopy on model
bilayers with metabolic tracing studies in cells, we demonstrate that light-induced alterations in the
lateral packing of caCers lead to marked differences in their metabolic conversion by
sphingomyelin synthase and glucosylceramide synthase. These changes in metabolic rates are
instant and reversible over several cycles of photoswitching. Our findings disclose new
opportunities to probe the causal roles of ceramides and their metabolic derivatives in a wide array
of sphingolipid-dependent cellular processes with the spatiotemporal precision of light.
DOI: https://doi.org/10.7554/eLife.43230.001
Introduction
Sphingolipids are unusually versatile membrane components in eukaryotic cells that contribute to
mechanical stability, cell signaling and molecular sorting (Holthuis et al., 2001). They derive from
the addition of various polar head groups to ceramide, a hydrophobic molecule containing saturated
or trans-unsaturated acyl chains linked to a serine backbone (Wegner et al., 2016). The enzymes
responsible for sphingolipid production and turnover comprise a complex metabolic network that
gives rise to numerous bioactive molecules. Intermediates of sphingolipid metabolism, notably
sphingosine, ceramide and their phosphorylated derivatives, influence a multitude of physiological
processes, including cell proliferation, cell death, migration, stress adaptation, immune responses
and angiogenesis (Hannun and Obeid, 2018). Consequently, imbalances in sphingolipid metabolism
are linked to major human diseases (Ogretmen, 2018).
Sphingomyelin (SM) and glycosphingolipids (GSLs) are the main sphingolipid classes in mammals
(Koval and Pagano, 1991; D’Angelo et al., 2013). SM forms a concentration gradient along the
secretory pathway and influences cellular cholesterol homeostasis to sustain vital physical properties
of the plasma membrane, where SM and Chol are enriched (Slotte, 2013). The hydrolysis of plasma
membrane SM by sphingomyelinases generates ceramide, which mediates several stress responses
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including cell cycle arrest, senescence and apoptosis (Adada et al., 2016). SM biosynthesis is medi-
ated by SM synthase (SMS), an enzyme catalyzing the transfer of phosphocholine from phosphatidyl-
choline (PC) onto ceramide, yielding SM and diacylglycerol (DAG). Mammals contain two SMS
isoforms, namely SMS1, responsible for bulk production of SM in the Golgi lumen, and SMS2, serv-
ing a role in regenerating SM from ceramides released by sphingomyelinases on the cell surface
(Huitema et al., 2004; Yamaoka et al., 2004). Besides their biological potential as cross-regulators
of the pro-apoptotic factor ceramide and mitogenic factor DAG, studies in mice revealed roles for
SMS1 and SMS2 in inflammation, atherosclerosis and diabetes (Mitsutake et al., 2011; Li et al.,
2011; Liu et al., 2009). Conversely, GSLs are synthesized by the sequential action of Golgi-resident
glycosyltransferases. These enzymes conjugate ceramide to a specific carbohydrate from a sugar
nucleotide (e.g. UDP-glucose, UDP-galactose), or onto a ceramide-conjugated carbohydrate chain,
giving rise to a large variety of structurally and functionally divergent compounds (D’Angelo et al.,
2013). While GSLs are dispensable for cell survival, they are key to cell-cell communication and col-
lectively required for mammalian development (D’Angelo et al., 2013; Yamashita, 2000).
Progress in understanding how sphingolipids exert their multitude of tasks is hindered by a lack
of suitable methods to probe lipid function (Honigmann and Nadler, 2018). Manipulation of cellular
lipid pools by altering expression of metabolic enzymes is a slow process, allowing cells to mount an
adaptive response that dampens functional impact. The fact that lipid metabolic networks are highly
interconnected also makes it difficult to prove that the direct product of a specific enzyme is the
actual effector. Chemical dimerizers and optogenetic approaches allow researchers to manipulate
lipid levels more rapidly, but their application often requires extensive protein engineering and is
largely restricted to soluble lipid-metabolic enzymes or transfer proteins (Jain et al., 2017). Another
method to rapidly increase lipid supply involves the use of caged lipids. These compounds carry a
photo-labile protecting group that blocks their biological activity until the active lipid is released
with a flash of light (Kim et al., 2016; Ho¨glinger et al., 2014; Ho¨glinger et al., 2015). Alongside
the recent development of site-directed variants of caged sphingosine, it has become possible to
confine release of this bioactive lipid to specific organelles (Feng et al., 2018). However, once trig-
gered, the activity cannot be switched off and the decay of the lipid signal depends on its metabolic
conversion. In this respect, photoswitchable azobenzene-containing lipids hold great promise by
allowing the translation of optical stimuli into a reversible cellular response (Frank et al., 2015;
Frank et al., 2016a; Frank et al., 2016b). In previous studies, we demonstrated the potency of azo-
benzene-containing fatty acids as photoswitchable agonists of the vanilloid receptor 1 (Frank et al.,
2015), and found that photoswitchable DAGs enable light-mediated oscillations in protein kinase C
activation (Frank et al., 2016a).
We recently synthesized a set of azobenzene-containing ceramides (ACes) to exert optical control
over the curvature of the N-acyl chain. All three ACes displayed a light-dependent cycling between
liquid-ordered (Lo) and liquid-disordered (Ld) domains when incorporated into phase-separated sup-
ported lipid bilayers (SLBs), thus enabling dynamic manipulation of membrane structure and fluidity
(Frank et al., 2016b). Whether such light-mediated restructuring of membranes can also be imple-
mented in living systems remained unclear. Moreover, whether azo-ceramides can be exploited to
reversibly manipulate sphingolipid metabolism or function remained to be established. Here, we
introduce a new generation of photoswitchable ceramides containing an azobenzene in the sphin-
goid base or N-acyl chain, along with a clickable alkyne group for increased metabolite detection
sensitivity. Using both synthetic bilayers and living cells as experimental models, we demonstrate the
potential of these compounds as photoswitchable substrates to place sphingolipid biosynthesis
under the dynamic control of light.
Results
Chemical synthesis of clickable and photoswitchable ceramides
We designed and synthesized four clickable and azobenzene-containing ceramide analogues, caCer-
1–4 (Figure 1a,b, Supplementary file 1). Each caCer has an N-acyl chain possessing a terminal
alkyne for click-derivatization with a fluorophore reporter. caCer-1 is a clickable variant of ACe-1 on
which we reported earlier (Frank et al., 2016b) (Figure 1c), and carries the azobenzene photoswitch
in its N-acyl chain with the diazene group mimicking a D9-double bond. caCer-2 has a shorter N-acyl
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Figure 1. Design and synthesis of clickable and photoswitchable ceramides. (a) Chemical structure of C16:0-Cer, with color-coded sphingoid base
(black) and N-acyl chain (red). (b) Chemical structures of clickable and photoswitchable ceramides caCer-1–4. (c) Chemical structures of clickable
ceramide cCer and photoswitchable ceramide ACe-1. (d) caCer-1 undergoes reversible isomerization between its cis- and trans-configuration with UV-A
(365 nm) and blue (470 nm) light, respectively. (e) Chemical synthesis of the photoswitchable sphingoid base aSph-1, which was N-acylated with a
terminal alkyne-functionalized C15 fatty acid to afford caCer-3. (f) UV-Vis spectra of the red-shifted variant caCer-3 (50 mM in DMSO) in its dark-adapted
(trans, black), UV-A-irradiated (cis, violet) and blue-irradiated (trans, blue) states. (g) caCer-3 (50 mM in DMSO) undergoes isomerization to its cis-
configuration with UV-A light (350–390 nm), and this effect is completely reversed with blue light (465 nm). Photoswitching was monitored by measuring
the absorbance at 365 nm.
DOI: https://doi.org/10.7554/eLife.43230.002
The following figure supplements are available for figure 1:
Figure supplement 1. Chemical synthesis of caCer-1.
DOI: https://doi.org/10.7554/eLife.43230.003
Figure supplement 2. Chemical synthesis of caCer-2.
DOI: https://doi.org/10.7554/eLife.43230.004
Figure supplement 3. UV-Vis spectra of caCer-1, caCer-2 and Cer-4.
DOI: https://doi.org/10.7554/eLife.43230.005
Figure supplement 4. Chemical synthesis of caCer-4.
DOI: https://doi.org/10.7554/eLife.43230.006
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chain with an azobenzene whose diazene group mimics a D6-double bond. These two analogues
were synthesized by first converting the commercially available aldehyde 1 to terminal alkyne 2 with
the Ohira-Bestmann reagent (Ohira, 1989; Mu¨ller et al., 1996). A tin dichloride-mediated reduction
then afforded aniline 3, which was subjected to the Baeyer-Mills reaction (Baeyer, 1874;
Mills, 1895). Using different nitroso compounds, the functionalized fatty acids cFAAzo-4 (Figure 1—
figure supplement 1) and cFAAzo-1 (Figure 1—figure supplement 2) could be prepared. Amida-
tion of cFAAzo-4 and cFAAzo-1 with D-erythro-sphingosine afforded caCer-1 and caCer-2, respec-
tively. UV-Vis spectroscopy revealed that both compounds behaved as standard azobenzenes
(Figure 1—figure supplement 3a,b). In the dark, they existed in their thermally stable trans-configu-
ration, and could be isomerized to cis using UV-A (350–390 nm) illumination. The trans-isomer could
be regenerated using blue (470 nm) light (Figure 1d).
caCer-3 and caCer-4 were designed around two distinct azobenzene-containing sphingoid bases,
aSph-1 and aSph-2, which possessed either a two- or four-carbon linker between the head group
and the azobenzene, respectively (Figure 1e, Figure 1—figure supplement 4). The styrene aSph-1
was synthesized from 4-propylaniline, which was converted by Baeyer-Mills reaction to the hydroxy-
methyl azobenzene 5 (Figure 1e). Sequential oxidation to aldehyde 6 and Wittig reaction afforded
olefin 7. Cross-metathesis (Rai and Basu, 2004; Peters et al., 2007) of 7 with the L-serine-derived
allyl alcohol 8 (Garner, 1984; Garner and Park, 1992) followed by deprotection afforded aSph-1.
Acylation with the C15 terminal alkyne-tagged fatty acid 4 (Seike et al., 2006) (Figure 1—figure
supplement 4a) afforded caCer-3 (Figure 1e). caCer-4 was prepared in an analogous fashion from
aSph-2 (Figure 1—figure supplement 4b). UV-Vis spectroscopy revealed that the styrene caCer-3
possessed a slightly red-shifted absorption spectrum, with a lmax at 365 nm (Figure 1f) compared to
about 335 nm for the rest of the caCers (Figure 1—figure supplement 3). To determine the optimal
photoswitching wavelength to generate cis-caCer-3, we continuously monitored the absorbance at
365 nm in solution and performed a wavelength scan between 350 to 410 nm. We found that the
trans to cis isomerization of caCer-3 was most efficient at 370 nm, similar to the rest of the caCers
and ACes (Frank et al., 2016b) (Figure 1g). caCer-4 possessed similar absorption spectra as caCer-
1 and caCer-2 (Figure 1—figure supplement 3c).
caCers enable optical control of ordered lipid domains in supported
bilayers
We previously reported that N-acyl-azobenzene ceramides analogous to caCer-1 and caCer-2, but
lacking the alkyne functionality, can be used to optically manipulate the structure of phase-separated
lipid domains in SLBs (Frank et al., 2016b). However, whether ceramides with azobenzene-contain-
ing sphingoid bases display a similar behavior in such lipid environments was still in question. We
therefore performed confocal fluorescence imaging and scanning atomic force microscopy (AFM) on
SLBs containing a quaternary lipid mixture of 1,2-O-dioleoyl-sn-glycero-3-O-phosphocholine
(DOPC), cholesterol, SM (C18:0) and caCer-3 or caCer-4 at a molar ratio of 10:6.7:5:5 DOPC:choles-
terol:SM:caCer (Figure 2). Each lipid mixture was doped with 0.1 mol% ATTO-655-DOPE to allow
visualization of domain segregation in the SLB using confocal microscopy through the preferential
localization of the dye in liquid-disordered (Ld) membrane regions (Frank et al., 2016b). Confocal
fluorescence imaging of SLBs from lipid mixtures containing the dark-adapted trans-caCers revealed
a clear phase separation, with liquid-ordered (Lo) domains appearing as dark regions (Figure 2a).
Imaging of the SLBs by AFM confirmed the formation of Lo domains, which rested approximately
1 nm above the Ld phase (Figure 2b). UV-A-induced isomerization of dark-adapted caCers to cis led
to a rapid fluidification of the Lo domains, as indicated by the appearance of many small liquid-disor-
dered (Ld) ‘lakes’ within the Lo domains, alongside an increase in the Ld/Lo area ratio. During equili-
bration, these lakes laterally diffused toward the Ld phase or coalesced into larger lakes in an effort
to minimize line tension. On isomerization of caCers to trans by blue light, the Ld lakes shrunk in size
while the surrounding Lo areas expanded, essentially occupying the same total area as in the original
dark-adapted state. These light-induced effects on lipid domains were observed for both caCer-3
(Figure 2b, top) and caCer-4 (Figure 2b, bottom) and could be repeated over multiple cycles of
UV-A and blue light illumination (Figure 2c, Figure 2—video 1 and 2). This indicates that, while
trans-isomers of caCer-3 and caCer-4 preferentially localize to cholesterol- and SM-rich Lo domains,
their cis-isomers favor association with more loosely packed lipids like DOPC. Hence, ceramides
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Figure 2. Photo-isomerization of caCers affects membrane fluidity and lipid domain structure in supported lipid bilayers. (a) Confocal fluorescence
microscopy of SLBs containing a quaternary mixture of DOPC:cholesterol:SM:caCer (10:6.7:5:5 mol ratio) and 0.1 mol% ATTO655-DOPE. Images of
SLBs prepared with dark-adapted trans-caCer-3 and trans-caCer-4 revealed phase separation, with taller liquid-ordered (Lo) domains appearing as dark
regions in a liquid-disordered (Ld) phase. Scale bars, 10 mm. (b) Atomic force microscopy of SLBs prepared as in (a). Isomerization of caCer-3 (top) and
caCer-4 (bottom) to cis with UV-A light (365 nm) resulted in a fluidification inside the Lo domains, as indicated by the appearance of small fluid Ld lakes
and an increased Ld/Lo area ratio. This effect was reversed on isomerization back to trans with blue light (470 nm), marked by a drop in the Ld/Lo area
ratio. Scale bars, 2 mm. (c) Time-course plotting the normalized Lo area over multiple 365/470 nm irradiation cycles for caCer-3 (top) and caCer-4
(bottom).
DOI: https://doi.org/10.7554/eLife.43230.007
The following videos are available for figure 2:
Figure 2—video 1. Reversible remodeling of lipid domains by caCer-3.
DOI: https://doi.org/10.7554/eLife.43230.008
Figure 2—video 2. Reversible remodeling of lipid domains by caCer-4.
DOI: https://doi.org/10.7554/eLife.43230.009
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carrying the azobenzene in their sphingoid backbone display similar light-dependent preferences for
Lo and Ld domains as those reported for N-acyl-azobenzene ceramides (Frank et al., 2016b).
caCers are light-sensitive substrates of SM synthase
To address whether the photoswitchable properties of caCers can also be exploited in native cellular
membranes, we first monitored their metabolic conversion into SM by human SMS2 heterologously
expressed in yeast. To this end, caCers were kept in the dark or pre-irradiated with blue or UV-A
light, and then incubated with lysates of yeast cells transfected with V5-tagged SMS2 or an empty
vector (EV) (Figure 3a,b). A clickable ceramide analogue lacking the azobenzene moiety, cCer
(Figure 1c), served as control. Next, the lipids were extracted, click-reacted with a fluorophore, sep-
arated by thin layer chromatography (TLC) and analyzed for fluorescence. To detect the clickable lip-
ids, we initially used 3-azido-7-hydroxycoumarin as a fluorogenic click-reagent (Sivakumar et al.,
2004; Thiele et al., 2012). However, this resulted in a distance-dependent intramolecular quenching
of the coumarin fluorescence by the caCer azobenzene moiety (Figure 3—figure supplement 1). As
Alexa-647 has no spectral overlap with the azobenzene, Alexa-647-azide was used in all subsequent
click reactions. All four caCers and cCer were converted into SM when incubated with lysates of
SMS2-expressing yeast cells (Figure 3c). No conversion was observed in lysates of control (EV) cells.
Strikingly, the cis (UV-A-irradiated) isomers of both caCer-1 and caCer-2 were more efficiently
metabolized by SMS2 than their corresponding trans (dark-adapted or blue-irradiated) isomers.
caCer-3 behaved similarly to caCer-1 and caCer-2, except that its blue irradiation led to a higher
metabolic conversion by SMS2 (Figure 3c). In contrast, the SMS2-mediated conversion of both
caCer-4 and cCer was independent of light treatment. The same trends were observed when the
click reaction was omitted, and the azobenzene-containing lipids were visualized using the UV-
absorbing properties of the azobenzene group (Figure 3—figure supplement 2).
To exclude the possibility that the light-dependent metabolic conversion of caCers was merely
due to differences in the efficiency by which externally added trans- and cis-isoforms were incorpo-
rated into SMS2-containing membranes, we produced SMS2 cell-free in the presence of liposomes
already containing the caCer probe (Figure 3d,e). Here, we focused on caCer-1, as the metabolic
conversion of this compound in SMS2-containing lysates was most strongly influenced by light
(Figure 3c). During the liposome-coupled translation of SMS2 mRNA overnight at 26˚C, only trace
amounts of dark-adapted caCer-1 were converted into SM (Figure 4f, t = 0). Extending the incuba-
tion by 1 hr at 37˚C in the dark resulted in only a minor increase in the amount of SM formed. How-
ever, extending the incubation under pulsed UV-A illumination led to a rise in the amount of SM
produced. In contrast, blue illumination did not enhance SM production relative to the dark-adapted
liposomes. No such light-induced fluctuations in SM production were observed with liposomes con-
taining cCer. Omission of SMS2 mRNA abolished SM formation altogether (Figure 3f). Collectively,
these results indicate that light-induced conformational changes in caCers have an acute impact on
their metabolic conversion by SMS2 in both synthetic and cellular membranes.
Optical manipulation of SM biosynthesis in living cells
We next examined whether metabolic conversion of caCers by SMS2 can be controlled in a revers-
ible manner using the temporal precision of light. Cis- or trans-isomers of caCer-1 and caCer-3 were
added to lysates of SMS2-expressing yeast cells, and the reactions were then incubated at 37˚C
under different light regimes. After each 10 min period, the caCer configuration was switched by illu-
minating the reactions with blue or UV-A light. The amount of SM formed was monitored over time
by TLC analysis of Alexa-647-clicked reaction samples. The efficiency by which both caCer-1 and
caCer-3 were converted into SM increased instantly upon their isomerization to cis with UV-A light
(Figure 4). Conversely, isomerization back to trans with blue light resulted in an abrupt drop in the
SM production rate. This block in SM production could be reversed again by illuminating the sam-
ples with UV-A light. These trends could be repeated over two cycles with two different light
regimes (Figure 4a,b), thus enabling the generation of time-resolved pulses of SM synthesis. In line
with our foregoing data, the light-induced changes in SM production rates were more pronounced
for caCer-1 than for caCer-3, and metabolic conversion of cCer into SM was not affected by UV-A
or blue irradiation (Figure 4a,b).
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Figure 3. caCers are light-sensitive substrates of sphingomyelin synthase SMS2. (a) Blue, UV-A or dark-adapted caCers were incubated with lysates of
control or SMS2-expressing yeast cells for 30 min at 37˚C and their metabolic conversion to SM was determined by TLC analysis of total lipid extracts
click-reacted with Alexa-647. (b) Lysates of yeast cells transfected with empty vector (EV) or V5-tagged SMS2 were analyzed by immunoblotting with an
anti-V5 antibody. (c) Lysates of control (EV) and SMS2-expressing yeast cells were incubated with caCers or cCer as outlined in (a). Reaction samples
Figure 3 continued on next page
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To investigate whether caCers also enable optical control over SM biosynthesis in living cells, we
used SMS2-overexpressing HeLa cells generated by stable transfection with a V5-tagged SMS2
expression construct (Figure 5a). As expected, immunofluorescence microscopy revealed that the
bulk of SMS2-V5 resides at the plasma membrane (Figure 5b,c) (Huitema et al., 2004;
Tafesse et al., 2007). Next, control and SMS2-overexpressing HeLa cells were incubated with exter-
nally-added cis- (UV-A-irradiated) or trans- isomers (blue-irradiated or dark-adapted) of caCer-1 and
caCer-3 for 1 hr at 37˚C, and their conversion into SM was determined by TLC analysis of Alexa-647-
clicked total lipid extracts. The overall yield of SM produced in SMS2-overexpressing cells was at
least threefold higher than that in control cells, regardless of the caCer isomer used (Figure 5d–g).
However, in both control and SMS2-overexpressing cells, cis-caCer-1 was more efficiently metabo-
lized into SM than the trans-isomer (Figure 5d,e), and similar results were obtained with caCer-3
(Figure 5f,g).
To address whether the rate of SM production in living cells could be controlled reversibly,
SMS2-overexpressing cells were incubated with a trans (dark-adapted) isomer of caCer-1 or with
cCer for 15 min at 37˚C in the dark. Cells were then flash-illuminated with blue followed by UV-A
light or vice-versa, and then incubated for another 20 min in the dark. Cells that did not receive any
light treatment and that were kept in the dark throughout the incubation period served as baseline
for the conversion of the trans-isomer only. The amount of SM formed was then determined by TLC
analysis of Alexa-647-clicked total lipid extracts. Cells treated first with UV-A followed by blue-light
produced similar amounts of SM as cells kept in the dark (Figure 5h,i). However, treating cells first
with blue light followed by UV-A light caused a marked (3–5-fold) increase in SM production. In con-
trast, production of SM from cCer was not affected by light treatment, demonstrating that UV-A irra-
diation itself did not affect SM-production in HeLa cells. Taken together, these results demonstrate
the suitability of caCers as photoswitchable substrates for manipulating SM biosynthesis in living
cells with the temporal precision of light.
caCers enable optical manipulation of GlcCer biosynthesis
Finally, we addressed whether caCers can be used as light-sensitive substrates of other sphingolipid
biosynthetic enzymes. We employed a yeast strain expressing human glucosylceramide synthase
(GCS; Figure 6a), a Golgi-resident enzyme structurally unrelated to SMS2 that generates glucosyl-
ceramide (GlcCer) by transferring glucose from UDP-glucose to ceramide. When incubated with
lysates of GCS-expressing yeast cells in the presence of UDP-glucose, UV-A-irradiated caCer-1 was
converted to GlcCer (Figure 6b). No GlcCer was formed when UDP-glucose was omitted or when
yeast lysates that lack GCS were used. Analogous to our results with SMS2, metabolic conversion of
caCer-1 by GCS was light sensitive, with the cis-isomers being more readily converted to GlcCer
than the trans-isomers (Figure 6c,d). To address whether the rate of GlcCer production from caCers
could be reversibly manipulated, GCS-containing yeast lysates were incubated with a trans (dark-
adapted) isomer of caCer-1 or with cCer for 15 min at 37˚C in the dark. The lysates were then flash-
illuminated with blue light followed by UV-A light or vice-versa, and then incubated for another 20
min in the dark. Subjecting trans-caCer-1-containing lysates to an ‘off-ON’ switching regime (blue
then UV-A) enabled GlcCer production (Figure 6e). In contrast, keeping the lysates in the dark or
Figure 3 continued
were subjected to lipid extraction, click-reacted with Alexa-647 and analyzed by TLC. (d) SMS2 was produced cell-free in the dark at 26˚C in the
presence of caCer-containing liposomes and then incubated at 37˚C in the dark or upon illumination with blue or UV-A light. Reaction samples were
subjected to lipid extraction, click-reacted with Alexa-647 and analyzed by TLC. (e) Cell-free translation reactions with or without SMS2-V5 mRNA were
analyzed by immunoblotting with an anti-V5 antibody. (f) SMS2 was produced cell-free in the presence of caCer-1 or cCer-containing liposomes and
then incubated for 0 or 60 min at 37˚C as outlined in (d). Reaction samples were subjected to lipid extraction, click-reacted with Alexa-647 and analyzed
by TLC.
DOI: https://doi.org/10.7554/eLife.43230.010
The following figure supplements are available for figure 3:
Figure supplement 1. Monitoring SMS2-mediated metabolic conversion of caCers and cCer using 3-azido-7-hydroxycoumarin as click reagent.
DOI: https://doi.org/10.7554/eLife.43230.011
Figure supplement 2. Monitoring SMS2-mediated metabolic conversion of caCers independently of fluorescent click-reagents.
DOI: https://doi.org/10.7554/eLife.43230.012
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Figure 4. Metabolic conversion of caCers by SMS2 in cell lysates can be switched on and off by light. (a) caCer-1, caCer-3 or cCer were incubated with
lysates of SMS2-expressing yeast cells at 37˚C under UV-A or blue illumination. After each 10 min period, the caCer configuration was switched by
illuminating the reactions with blue or UV-A light. Reaction samples were taken at the indicated time points, subjected to lipid extraction, click-reacted
with Alexa-647 and then analyzed by TLC. Presented are the relative amounts of SM formed per time point. (b) Presented are the relative SM
Figure 4 continued on next page
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subjecting them to an ‘on-OFF’ switching regime (UV-A then blue) blocked GlcCer production. In
lysates containing cCer, GlcCer production was independent of light (Figure 6c–e). To conclude, we
produced GCS cell-free in the presence of UDP-glucose and liposomes that contained either dark-
adapted caCer-1 or cCer (Figure 6f). While only small amounts of GlcCer were formed when caCer-
1-containing proteoliposomes were kept in the dark, GlcCer production was strongly stimulated by
UV-A illumination (Figure 6g). In contrast, GlcCer production in cCer-containing proteoliposomes
was insensitive to UV-A illumination. Importantly, these results demonstrate that the application of
caCers as light-sensitive substrates is not restricted to one particular class of ceramide metabolic
enzymes.
Discussion
Studies of lipid function traditionally revolve around an extended central dogma of molecular biol-
ogy: that proteins control cellular lipid pools by catalyzing lipid metabolism and transport. As such,
interrogating lipid function by manipulating gene expression or protein activity is intrinsically slow
and indirect. Photo-activated lipids allow one to probe lipid function in a more acute and direct man-
ner using the unmatched temporal precision of light. Here, we report on caCers, a new generation
of clickable and azobenzene-containing ceramide analogs that enable optical control over sphingoli-
pid production in living cells. Isomerization of the azobenzene photoswitch triggers conformational
changes in the carbon chains of caCers that either block or facilitate their metabolic conversion by
SMS2 and GCS, two key sphingolipid biosynthetic enzymes in mammals. Our finding that these
light-induced effects are instant, reversible and occur in native cellular membranes opens up unprec-
edented opportunities to manipulate the metabolic fate and biological activity of sphingolipids at
the subcellular level in real time.
Using synthetic and cellular membrane systems as experimental models, we found that cis-iso-
mers of caCer-1, caCer-2 and caCer-3 are more readily metabolized by SMS2 than their correspond-
ing trans-isomers. These observations may seem counterintuitive at first, as trans-caCers resemble
natural ceramides more closely than cis-caCers, possessing kinked carbon chains instead of straight
ones. One explanation for this may be that the trans-azobenzene moiety interferes with high-affinity
binding of caCers to the ceramide binding pocket in SMS2, for instance because the enzyme prefer-
entially accommodates substrates with bent carbon chains (Figure 7a). However, this theory conflicts
with the finding that SM synthases are relatively tolerant toward structural deviations in the ceramide
backbone and readily metabolize ceramide analogous with distinct functional groups in the sphin-
goid base or N-acyl chain (Koval and Pagano, 1991; Huitema et al., 2004; Haberkant et al.,
2016). Moreover, the unrelated enzyme GCS also converts cis-caCers more rapidly, suggesting that
a general biophysical property of the caCers underlies this phenomenon.
Based on our findings in SLBs, we hypothesize that the impact of cis-trans isomerization on the
metabolic fate of caCers may be caused by light-induced alterations in their lateral packing
(Figure 7b). According to this model, trans-caCers form tightly packed clusters due to favorable
intermolecular stacking interactions among the flat trans-azobenzene groups, thereby reducing their
availability for enzymatic conversion. On isomerization to cis, the kinked caCer molecules become
dispersed throughout the membrane, making them more accessible for enzymatic conversion. This
idea is supported by our finding that trans-caCers preferentially localize in liquid-ordered (Lo)
domains in model bilayers (Figure 2) (Frank et al., 2016b). caCer-4 forms an exception, as its
isomerization to trans promotes association with Lo domains without having an obvious impact on
SM biosynthesis. While both caCer-3 and caCer-4 have azobenzene-containing sphingoid bases,
Figure 4 continued
production rates (a.u. of SM formed per min) calculated from the time points presented in (a). Data shown are average values ± s.d. from four technical
replicates (n = 4).
DOI: https://doi.org/10.7554/eLife.43230.013
The following source data is available for figure 4:
Source data 1. Quantitation of metabolic conversion of caCers by SMS2 in cell lysates.
DOI: https://doi.org/10.7554/eLife.43230.014
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Figure 5. caCers enable optical control of SMS2-mediated SM biosynthesis in living cells. (a) HeLa cells stably transfected with V5-tagged SMS2 were
analyzed by immunoblotting using anti-V5 and anti-calnexin antibodies. Untransfected HeLa cells served as control. (b) Control and SMS2-V5-
expressing HeLa cells were fixed, co-stained with antibodies against the V5 epitope and Golgi marker GM130, and then visualized by fluorescence
microscopy. Scale bar, 10 mm. (c) Intensity plots along the path marked by the white arrow, showing overlap between anti-V5 (green) and anti-GM130
Figure 5 continued on next page
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caCer-4 is unique among all caCers in that its azobenzene photoswitch is positioned close to the
end of the carbon chain. Conceivably, isomerization of this compound to trans may lead to a less
pronounced clustering in cellular membranes.
A distinct advantage of caCers over caged ceramide analogs (Kim et al., 2016; Ho¨glinger et al.,
2014; Ho¨glinger et al., 2015) is that their activity can be readily switched off by light. This property
enabled us to generate time-resolved pulses of SM synthesis at the plasma membrane of living cells.
In comparison to traditional pulse-chase approaches, our method offers superior temporal resolution
for manipulating sphingolipid levels, and could be combined with patterned illumination to generate
controlled sphingolipid pulses in subpopulations of cells or in subcellular organelles. An attractive
prospect is to use cis-trans isomerization to bring caCers within reach of the binding pocket of a cer-
amide signaling protein, or to pull them away, thus enabling instant and reversible control over cer-
amide-operated signaling pathways (Figure 7). Accordingly, caCers may find use in dissecting the
causal roles of ceramides in apoptosis, as tumor suppressors, and as antagonists of insulin signaling
(Hannun and Obeid, 2018; Jain et al., 2017; Park et al., 2016; Meikle and Summers, 2017). In
fact, light-induced changes in lateral packing may be a previously unnoted characteristic of other
azobenzene-containing signaling lipids like DAGs, where the cis-isomers correspond to the bioactive
form (Frank et al., 2016a; Leinders-Zufall et al., 2018).
Application of caCers in living cells is hampered by their relatively poor aqueous solubility. How-
ever, the development of photoswitchable sphingoid bases may provide a way to circumvent limita-
tions associated with the relative inefficient uptake of caCers by cells, thus expanding opportunities
for manipulating the metabolic fate and signaling activity of sphingolipids by light. Ceramides are
the precursors of a large collection of complex sphingolipids with critical roles in sustaining mechani-
cal stability, molecular sorting, cell signaling, migration and adhesion. Consequently, caCers provide
attractive scaffolds for creating a new toolbox of photoswitchable sphingolipids to enable optical
control over a wide array of sphingolipid-mediated cellular processes.
Materials and methods
General chemical synthesis
Clickable ceramide (cCer) was synthesized as previously described (Kol et al., 2017). Unless other-
wise stated, all reactions were performed with magnetic stirring under a positive pressure of nitro-
gen or argon gas. Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled over sodium
benzophenone under nitrogen atmosphere prior to use. Dichloromethane (CH2Cl2) and triethylamine
(Et3N) were distilled over calcium hydride under a nitrogen atmosphere. N,N-dimethylformamide
(DMF), toluene (PhMe), dioxane and methanol (MeOH) were purchased from Acros Organics as
’extra dry’ reagents under inert gas atmosphere and stored over molecular sieves. Ethyl acetate
Figure 5 continued
(magenta) channels. (d) Blue, UV-A or dark-adapted caCer-1 was incubated with control or SMS2-V5-expressing HeLa cells for 1 hr at 37˚C. Metabolic
conversion of caCer-1 to SM was determined by TLC analysis of total lipid extracts click-reacted with Alexa-647. (e) Quantitative analysis of SM formed
from caCer-1 by cells treated as in (c). (f) Blue, UV-A or dark-adapted caCer-3 was incubated with control or SMS2-V5-expressing HeLa cells for 1 hr at
37˚C and its metabolic conversion to SM was determined as in (c). (g) Quantitative analysis of SM formed from caCer-3 by cells treated as in (e). (h)
caCer-1 or cCer were incubated with SMS2-V5-expressing HeLa cells at 37˚C in the dark. After 15 min, cells were flash-illuminated by blue light
followed by UV-A or vice versa and then incubated for another 20 min. Cells kept in the dark for the entire incubation period served as control.
Metabolic conversion of caCer-1 or cCer to SM was determined by TLC analysis of total lipid extracts click-reacted with Alexa-647. (i) Quantitative
analysis of SM formed from caCer-1 or cCer by cells treated as in (g). Data shown are mean values ± s.d. from three biological replicates (n = 3).
DOI: https://doi.org/10.7554/eLife.43230.015
The following source data is available for figure 5:
Source data 1. Quantitation of metabolic conversion of pretreated caCer1 by SMS2 in living HeLa cells.
DOI: https://doi.org/10.7554/eLife.43230.016
Source data 2. Quantitation of metabolic conversion of pretreated caCer3 by SMS2 in living HeLa cells.
DOI: https://doi.org/10.7554/eLife.43230.017
Source data 3. Quantitation of live manipulation of metabolic conversion of caCer1 and cCer by SMS2 in living HeLa cells.
DOI: https://doi.org/10.7554/eLife.43230.018
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(EtOAc), pentane, Et2O, CH2Cl2 and MeOH used specifically for extraction and flash column chroma-
tography were purchased at technical grade from commercial sources and distilled under reduced
pressure. Solvents and reagents were used as received from commercial sources (Sigma-Aldrich,
Tokyo Chemical Industry Co., Alfa Aesar, Acros Organics, Strem Chemicals). Reactions were moni-
tored by thin-layer chromatography (TLC) using silica gel F254 pre-coated glass plates (Merck) and
visualized by exposure to ultraviolet light (l = 254 nm) or by staining with aqueous potassium per-
manganate (KMnO4) solution (7.5 g KMnO4, 50 g K2CO3, 6.25 mL aqueous 10% NaOH, 1000 mL dis-
tilled H2O), aqueous acidic ceric ammonium molybdate (IV) (CAM) solution (2.0 g Ce
(NH4)4(SO4)42H2O, 48 g (NH4)6Mo7O244H2O, 60 mL concentrated sulfuric acid, 940 mL distilled
H2O) or a butanolic ninhydrin solution (13.5 g ninhydrin, 900 mL n-BuOH, 27 mL acetic acid) followed
Figure 6. caCer-1 is a light-sensitive substrate of glucosylceramide synthase GCS. (a) Lysates of yeast cells transfected with V5-tagged GCS or empty
vector (EV; control) were analyzed by immunoblotting using anti-V5 and anti-Vti1p antibodies. (b) UV-A pretreated caCer-1 (25 mM) was incubated with
lysates of control or GCS-expressing yeast cells for 30 min at 37˚C in the presence or absence of 1 mM UDP-glucose. Reactions were subjected to lipid
extraction, click-reacted with Alexa-647 and then analyzed by TLC. (c) UV-A, blue or dark pretreated caCer-1 and cCer (25 mM, each) were incubated in
the dark for 30 min at 37˚C with lysates of GCS-expressing yeast in the presence of 1 mM UDP-glucose and analyzed as in (b). (d) Quantitative analysis
of GlcCer formed from caCer-1 or cCer in lysates treated as in (c). (e) Dark-adapted caCer-1 or cCer (25 mM, each) and UDP-glucose (1 mM) were
incubated with lysates of GCS-expressing yeast in the dark at 37˚C. After 15 min, lysates were flash-illuminated by blue light followed by UV-A or vice
versa and then incubated for another 20 min. Lysates kept in the dark for the entire incubation period served as control. GlcCer formation was
determined by TLC analysis of total lipid extracts click-reacted with Alexa-647. (f) Cell-free translation reactions with or without GCS-V5 mRNA were
carried out overnight in the dark at 26˚C. GCS was expressed in the presence of liposomes containing caCer-1 or cCer and then analyzed by
immunoblotting using an anti-V5 antibody. (g) GCS produced cell-free as in (f) was flash-illuminated with UV-A or kept in the dark and then incubated
with 1 mM UDP-glucose for 30 min at 37˚C in the dark. GlcCer formation was monitored by TLC as in (e). Data shown are average values ± s.d. (cCer,
n = 2; caCer-1, n = 3).
DOI: https://doi.org/10.7554/eLife.43230.019
The following source data is available for figure 6:
Source data 1. Quantitation of metabolic conversion of pretreated caCer-1 and cCer by GCS in cell lysates.
DOI: https://doi.org/10.7554/eLife.43230.020
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by heating with a heat gun (150–600˚C). Flash column chromatography was performed using silica
gel (60 A˚, 40–63 mm, Merck).
Proton (1H) and carbon (13C) nuclear magnetic resonance spectra were recorded on a Bruker
Avance III HD 400 MHz spectrometer equipped with a CryoProbe or a Varian VXR400 S spectrome-
ter. Proton chemical shifts are expressed in parts per million (ppm, d scale) and referenced to resid-
ual undeuterated solvent signals. Carbon chemical shifts are expressed in parts per million (ppm, d
scale) and referenced to the central carbon resonance of the solvent. The reported data is repre-
sented as follows: chemical shift in parts per million (ppm, d scale) (multiplicity, coupling constants J
in Hz, integration intensity, proton assignment). Abbreviations used for analysis of multiplets are as
follows: s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), p (pentet), h (hextet), and
m (multiplet). Variable temperature NMR spectroscopy was performed at the Ludwig-Maximilians-
Universita¨t NMR facility.
IR spectra were recorded on a PerkinElmer Spectrum BXII FTIR spectrometer equipped with an
attenuated total reflection (ATR) measuring unit. IR data is recorded in frequency of absorption
(wavenumber in cm 1). Mass spectrometry (MS) experiments were performed at high resolution on a
Thermo Finnigan MAT 95 (electron ionization [EI] double-focusing magnetic sector mass spectrome-
ter) or on a Thermo Finnigan LTQ FT (electrospray ionization [ESI] linear ion trap-based Fourier trans-
form ion cyclotron resonance mass spectrometer) instrument at the Ludwig-Maximilians-Universita€t
mass spectrometry facility. Melting points were measured using a Stanford Research Systems
MPA120 Automated Melting Point Apparatus in open capillaries and are uncorrected.
Figure 7. Models of how photoswitchable ceramides may enable optical control over sphingolipid biosynthesis and signaling. (a) UV-A or blue light
trigger alterations in the curvature of the carbon chains of azobenzene-containing ceramides (caCers), which reversibly enhance or reduce their affinity
for ceramide metabolic enzymes and signaling proteins. (b) Blue light triggers self-assembly of photoswitchable ceramides (caCers) into tightly packed
clusters driven by intermolecular stacking of the flat trans-azobenzene groups. In contrast, UV-A light causes caCers to disperse in the plane of the
membrane as the bent cis-azobenzene groups disrupt intermolecular stacking. These light-induced changes in lateral packing of caCers reversibly
enhance or reduce their availability for metabolic conversion or stimulating ceramide signaling proteins.
DOI: https://doi.org/10.7554/eLife.43230.021
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Supported lipid bilayer formation
N-Stearoyl-D-erythro-sphingosine (C18:0-Cer), N-stearoyl-D-erythro-sphingosylphosphoryl-choline
(C18:0-SM), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and cholesterol were purchased from
Avanti Polar Lipids (Alabaster, AL, USA). We prepared supported lipid bilayers (SLBs) by deposition
and fusion of small unilamellar vesicles (SUVs) as described elsewhere (Chiantia et al., 2006). SUVs
composed of DOPC:cholesterol:SM:caCer, containing additional 0.1 mol% ATTO655-DOPE (ATTO
Technology GmbH, Siegen, Germany), were obtained by bath sonication of multilamellar vesicles.
SUV suspensions (1 mM total lipid concentration in buffer containing 10 mM HEPES, 150 mM NaCl,
pH 7.4) were deposited in the presence of 2 mM CaCl2 on freshly-cleaved mica glued to glass cover-
slips. The samples were incubated at 65 ˚C for 30 min, rinsed with buffer and then allowed to cool
slowly to room temperature for at least 1 hr.
Combined atomic force and confocal microscopy
Combined atomic force and confocal microscopy was performed on a JPK Instruments Nanowizard
III BioAFM and Nanowizard Ultra (Berlin, Germany) mounted on a Zeiss LSM510 Meta laser scanning
confocal microscope (Jena, Germany). High-speed AFM in AC mode was done with the Nanowizard
Ultra head, utilizing USC-F0.3-k0.3 ultra-short cantilevers from Nanoworld (Neuchaˆtel, Switzerland)
with typical stiffness of 0.3 N/m. The cantilever oscillation was tuned to a frequency of 100–150 kHz
and the amplitude kept below 10 nm. The scan rate was set to 25–150 Hz. Images were acquired at
256  256 pixel resolution. All measurements were performed at room temperature. The force
applied on the sample was minimized by continuously adjusting the set point and gain during imag-
ing. Height, error, deflection and phase-shift signals were recorded and images were line-fitted as
required. Data was analyzed using JPK data processing software Version 5.1.4 (JPK Instruments) and
Gwyddion Version 2.30 (Czech Metrology Institute). For the confocal measurements, a 633 nm He-
Ne laser (to excite the 0.1 mol% ATTO655-DOPE added to the lipid mixtures) and a 40  NA 1.2
UV-VIS-IR C Apochromat water-immersion objective were used. All measurements were performed
at room temperature. Images were typically acquired with a 512  512 pixel resolution at a scan
rate of 3.2 ms/pixel and using a 1 Airy pinhole. Images were further processed with Fiji software
(http://fiji.sc/Fiji).
Compound switching on supported lipid bilayers
Compound switching for combined atomic force and confocal microscopy was achieved using a
CoolLED pE-2 LED light source (Andover, United Kingdom) for illumination at 365 and 470 nm. The
light source was operated at a maximum of 80% power. The light beam was guided by a fiber-optic
cable directly through the objective of the microscope via a collimator at the backport side of the
microscope.
Preparation of yeast lysates
The open reading frames of human SMS2 (uniProt entry Q8NHU3) and GCS (uniProt entry Q16739)
were PCR amplified and cloned into the pYES2.1/V5-His TOPO vector (Invitrogen) according to the
manufacturer’s instructions. Yeast strain IAY11 (MATa, ade2-1 trp1-1 can1-100 leu2-3,112 his3-11,15
ura3-52 ade3-D853) was transformed with pYES2.1/SMS2-V5-His, pYES2.1/GCS-V5-His, or an empty
vector control. For SMS2 expression, yeast was grown at 30˚C in synthetic medium containing 2%
(w/v) galactose to early mid-logarithmic phase. For GCS expression, yeast was grown in synthetic
medium with 2% (w/v) glucose to mid-log phase, washed twice with sterile water, and then grown in
synthetic medium with 2% (w/v) galactose for 4 hr. Cells were collected by centrifugation and
washed in ice-cold Buffer R (15 mM KCl, 5 mM NaCl, 20 mM HEPES/KOH pH 7.2). The wet cell pel-
let (2 g) was resuspended in buffer R (5 mL) containing protease inhibitor cocktail (PIC, 1 mg/mL
aprotinin, 1 mg/mL leupeptin, 1 mg/mL pepstatin, 5 mg/mL antipain, 1 mM benzamidine and 1 mM
phenylmethanesulfonyl fluoride). The cells were lysed by vigorous vortexing with glass beads (3 g) at
4 ˚C with intermittent cooling on ice. Post-nuclear supernatants were prepared by centrifugation at
700 xg for 10 min at 4 ˚C. The PNS of GCS-expressing yeast was centrifuged at 100,000 xg for 1 hr
at 4˚C and the resulting membrane pellet was resuspended in buffer R. After addition of 0.11 vol of
glycerol, the PNS and resuspended membranes were aliquoted, snap-frozen in liquid nitrogen and
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stored at  80 ˚C. Protein concentration of PNS and membrane samples was determined by Bio-Rad
Protein Assay (Bio-Rad GmbH, Munich, Germany).
Enzyme activity assay on yeast lysates
PNS of control or SMS2-expressing yeast were diluted to 0.3 mg/mL (Figure 3c) or 0.6 mg/mL total
protein (Figure 4) in Buffer R supplemented with PIC and 0.5 mM N-ethylmaleimide, and kept on
ice in 4 mL brown glass vials. Stocks of cCer and caCers (2 mM in EtOH) were stored in the dark at
 20 ˚C in 1.8 mL brown glass vials with ethylene-tetrafluoroethylene (ETFE)-coated rubber seals.
After pre-treatment with high intensity illumination at 365 or 470 nm using a CoolLED pE-2 (80%
power, 1 min, on ice), cCer and caCers were added to 400 ml PNS at a final concentration of 25 mM
and immediately vortexed. After 10 min on ice in the dark, the reactions were shifted to 37 ˚C for 30
min and kept in the dark or subjected to low intensity flash illumination (pulse of 75 ms with 15 s
interval) with UV-A (~365 nm) or blue light (~460 nm) from the top of the reaction tube using a
home-built, 24 well plate-compatible pulsed LED illumination setup (Borowiak et al., 2015) while
shaking at 30 rpm. For photoswitch experiments (Figure 4, time point t = 10 min and t = 20 min),
the reactions were subjected to high intensity illumination at 365 or 470 nm with a CoolLED pE-2
(80% power) for 20 s at 25 ˚C and then incubated again at 37 ˚C in the dark. Membrane suspensions
of control or GCS-expressing yeast were diluted to 0.6 mg/mL total protein in Buffer R and supple-
mented with 1 mM UDP-glucose. Light-treated or dark-adapted cCer and caCers were added to
400 ml of membrane suspension at a final concentration of 25 mM in 4 mL brown glass vials and then
incubated at 37 ˚C for 30 min in the dark with gentle shaking. Reactions were stopped by addition
of 3.75 vol CHCl3:MeOH (1:2 vol:vol) and stored at  20 ˚C.
Enzyme activity assays on cell-free-produced SMS2 and GCS
The open reading frames of human SMS2 and GCS were PCR amplified in-frame with a C-terminal
V5 epitope, cloned into wheat germ expression vector pEU-Flexi, and subjected to in vitro transcrip-
tion and translation as described (Kol et al., 2017). Translation of SMS2 and GCS transcripts was
incubated overnight at 26 ˚C in the dark in the presence of liposomes (2 mM) comprising egg PC:
egg PE:wheatgerm PI:cCer/caCer (40:40:20:2 molar ratio). Next, translation reactions were split into
four aliquots. One aliquot served as the t = 0 control, and the other three were treated either with
UV-A or blue light, or kept in the dark, and subsequently incubated for 1 hr at 37 ˚C under pulsed
LED illumination or in the dark to record SMS2 activity. For GCS activity, 1 mM UDP-glucose was
added directly prior to splitting and light treatment, and the reactions were incubated for 30 min at
37 ˚C. Reactions were stopped by addition of 3.75 vol of CHCl3:MeOH (1:2 vol:vol) and stored at
 20 ˚C.
Enzyme assay on HeLa cells
HeLa cells (ATTC CCL-2) were cultured in DMEM supplemented with 9% FBS (PAN Biotech P40-
47500) at 37 ˚C under 5% CO2. HeLa cells were mycoplasma free. HeLa cells stably transfected with
pcDNA3.1-SMS2-V5-His-TOPO (Huitema et al., 2004) were cultured in the presence of 400 mg/mL
G418 (Biochrom A291-25). Cells were seeded at 200,000–300,000 cells per well of a 6-well plate
(Greiner CellStar 657160). After 8 hr, 4 mM sodium butyrate (SantaCruz SC 202341A, 1 M stock in
H2O) was added. After another 16 hr, the cells were washed with PBS and then incubated in 1 mL
phenol red-free Optimem (Gibco 11058–021, Thermo Scientific) per well. Stock solutions of cCer
and caCers (2 mM in DMSO, Applichem A3672) were pre-treated with high intensity illumination at
either 365 or 470 nm with a CoolLED pE-2 (80% power) for 1 min on ice or kept in the dark, and
then immediately added to the Optimem on the cells under reduced light conditions. Incubations
were performed at 37 ˚C under 5% CO2 in the dark (Figure 5c–f). Cells were trypsinized, re-sus-
pended and harvested in 1 mL PBS supplemented with PIC. Cells were then pelleted at 900 xg for 5
min at 4 ˚C. After removal of 900 ml of supernatant, the cell pellet was re-suspended in the remaining
100 ml and 375 ml CHCl3:MeOH (1:2 vol:vol) was added before samples were stored at  20 ˚C.
For live switch experiments (Figure 5g,h), cells were grown and treated with butyrate in T75
flasks, as described above. Cells were trypsinized, collected in DMEM, pelleted at 600 xg for 5 min
at RT, washed with phenol red-free Optimem and then resuspended at ±8106 cells/mL in phenol
red-free Optimem. From this cell suspension, 100 ml aliquots were transferred to 1.8 mL brown vials,
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supplemented with 60 mM dark-adapted cCer or caCer-1 (from 2 mM stocks in DMSO) and incu-
bated at 37 ˚C under 5% CO2 in the dark with gentle shaking at 600 rpm. Light treatment was per-
formed by high intensity illumination for 30 s at 20 ˚C with a CoolLED pE-2 at either 365 or 470 nm,
80% power output. Reactions were stopped by addition of 375 ml CHCl3:MeOH (1:2 vol:vol) and
stored at  20 ˚C.
Immunoblot analysis
Expression of V5-tagged SMS2 or GCS was verified by immunoblot analysis using a mouse monoclo-
nal anti-V5 antibody (ThermoFisher, cat. no. R960-25, 1:4000). Rabbit polyclonal anti-calnexin (Santa
Cruz, cat. no. SC11397, 1:2000) and anti-Vti1p antibodies (kind gift from Christian Ungermann, Uni-
versity of Osnabru¨ck, 1:2000) served as controls. Goat-anti-mouse and goat-anti-rabbit IgG HRP con-
jugates were obtained from ThermoFisher (cat. no. 31430, 1:4000) and Biorad (cat. no. 1706515,
1:4000), respectively. For detection, Pierce ECL reagent (ThermoFisher, cat. no. 32106) was used.
Immunoblots were processed using a ChemiDoc XRS + system (Bio-Rad) and ImageLab software.
Lipid extraction
Lipid extractions were performed in Eppendorf Protein LoBind tubes with a reference volume (one
vol) of 100 ml (sample) in 3.75 vol (375 ml) CHCl3:MeOH. After centrifugation at 21,000 xg for 10 min
at 4 ˚C, the supernatant was collected and transferred to a fresh tube containing one vol CHCl3 and
1.25 vol 0.45% NaCl to induce phase separation. After vigorous vortexing for 5 min at RT and subse-
quent centrifugation (5 min, 21,000 xg, RT), the organic phase was transferred to a fresh tube con-
taining 3.5 vol MeOH:0.45% NaCl (1:1 vol:vol). After vigorous vortexing for 5 min at RT and
subsequent centrifugation (5 min, 21,000 xg, RT), the organic phase (1.8 vol) was collected and used
for derivatization with clickable fluorophores.
Click reactions
Clickable fluorophores 3-azido-7-hydroxycoumarin (Jena Bioscience) and Alexa-647-azide (Thermo
Fisher) were dissolved in CH3CN to a final concentration of 10 mM and 2 mM, respectively, and
stored at  20 ˚C. Lipid extracts were transferred to Eppendorf Protein LoBind tubes, dried down in
a speedvac and dissolved in 10 ml CHCl3 (initial experiments) or directly dissolved in click mix (later
experiments), as indicated. The alkyne-functionalized lipids in 10 ml CHCl3 were clicked to 3-azido-7-
hydroxycoumarin or Alexa647-azide by incubation with 43 ml of a freshly prepared click reaction solu-
tion containing 0.45 mM of the clickable fluorophore and 1.4 mM tetrakis(acetonitrile)copper(I) tetra-
fluoroborate in CH3CN:EtOH (3:7, vol:vol) for 4 hr at 40 ˚C, followed by 12 hr at 12 ˚C without
shaking (Gaebler et al., 2013). The reaction was quenched by the addition of 150 ml MeOH, dried
down in a Christ RVC 2–18 speedvac under reduced pressure from a Vacuubrand MZ 2C diaphragm
vacuum pump, and dissolved in CHCl3:MeOH (2:1, vol:vol). In later experiments, dried lipid films
were directly dissolved in 25 ml of click mix. The click-mix was composed of CHCl3:CH3CN:EtOH
(19:16:66, vol:vol:vol), in which Alexa-647 was present at an equimolar ratio with respect to the cal-
culated amount of alkyne lipid (assuming 100% lipid recovery from the extraction). The tetrakis(ace-
tonitrile)copper(I) tetrafluoroborate was present as at 20-fold molar excess with respect to the
fluorophore. After incubation for 4 hr at 40 ˚C and 12 hr at 12 ˚C without shaking, the reaction mix-
tures were directly loaded on TLC.
TLC analysis
Click-reacted lipid extracts were applied at 120 nl/s to NANO-ADAMANT HP-TLC plates (Macherey
and Nagel) using a CAMAG Linomat 5 TLC sampler. The TLC was developed in CHCl3:MeOH:H2O:
AcOH (65:25:4:1, vol:vol:vol:vol) using the CAMAG ADC2 automatic TLC developer operated as fol-
lows: 30 s plate pre-drying, 5 min humidity control (against saturated KSCN solution), 10 min tank
saturation with eluent, after which the TLC was developed until the front reached 85 mm height, and
then dried for 5 min. Coumarin-derivatized and unclicked azobenzene lipids were analyzed using a
ChemiDoc XRS + imager with UV-trans-illumination (detection settings for Ethidium Bromide - stan-
dard filter) and Quantity One software (Bio-Rad). Alexa-647 derivatized lipids were visualized on TLC
using a Typhoon FLA 9500 Biomolecular Imager (GE Healthcare Life Sciences) operated with 650 nm
excitation laser, LPR filter, 50 mm pixel size and PMT voltage setting of 290 V. The amount of Alexa-
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647-derivatized SM or GlcCer was quantified using the ImageQuant TL toolbox software (GE health-
care) as a background-corrected band intensity normalized to the total clicked-lipid signal intensity
(SM +Cer or GlcCer +Cer) for each lane, to correct for occasional sample-to-sample differences in
click labeling efficiency. Next, the highest sample-normalized intensity of a particular time series was
normalized to the maximum intensity of the time series.
Statistical analysis
The error bars in the graphs represent the (relative) sample standard deviation. For each experiment,
the sample size n is reported in the figure legend. ‘Technical replicates’ refers to in vitro assays per-
formed on yeast lysates from a single batch on different days. ‘Biological replicates’ refers to assays
performed on cells, which were cultured on different days from the DMSO-stocks from the same
batch/passage number, then seeded and used in the experiment.
Compound synthesis and characterization
Synthesis of 1-(but-3-yn-1-yl) 4-nitrobenzene (2)
To a stirred solution of aldehyde 1 (141 mg, 0.787 mmol, 1.0 equiv.) in MeOH (10 mL) was added
K2CO3 (217 mg, 1.57 mmol, 2.0 equiv.) followed by dimethyl(1-diazo-2-oxopropyl)phosphonate
(Mu¨ller et al., 1996) (182 mg, 0.947 mmol, 1.2 equiv.) dropwise via syringe at ambient temperature.
After stirring for 2 hr, pH 7 buffer was added to the dark red mixture. The aqueous phase was
extracted with EtOAc (3  15 mL). The combined organic fractions were washed with water (15 mL)
and brine (15 mL), then dried over anhydrous magnesium sulfate, filtered and concentrated under
reduced pressure. The crude material was purified by flash column chromatography (65% CH2Cl2 in
hexanes) to afford alkyne 2 as a pale yellow powder (132 mg, 0.753 mmol, 95%) (McIntosh et al.,
2012; MacHin and Pagenkopf, 2011).
TLC (65% CH2Cl2 in hexane): Rf: 0.77.
1H NMR (CDCl3, 400 MHz, 25˚C): d 8.17 (d, J = 8.5 Hz,
2H), 7.41 (d, J = 8.5 Hz, 2H), 2.95 (t, J = 7.2 Hz, 2H), 2.55 (td, J = 7.2, 2.6 Hz, 2H), 2.01 (t, J = 2.6 Hz,
1H). 13C NMR (CDCl3, 101 MHz, 25˚C): d 148.01, 146.86, 129.53, 123.78, 82.64, 70.02, 34.52,
20.11. IR (neat, ATR): 3260, 3108, 3080, 2960, 2936, 2910, 2841, 1606, 1597, 1511, 1449, 1428,
1336, 1318, 1261, 1243, 1207, 1181, 1105, 1013, 944, 862, 848, 820, 805, 745, 697, 687, 675, 649,
631. HRMS (EI+): m/z calcd. for [C10H9NO2]
+: 175.0633, found: 175.0627. Melting point: 110–
111˚C.
Synthesis of 4-(but-3-yn-1-yl)aniline (3)
To a stirred solution of 2 (132 mg, 0.753 mmol) in EtOH (25 mL) was added SnCl2.2H2O (1.70 g,
7.53 mmol, 10 equiv.). The mixture was heated to reflux and stirred for 19 hr. The reaction mixture
was cooled to ambient temperature and 1M NaOH solution (50 mL) was added. The suspension was
diluted with CH2Cl2 (100 mL) and filtered through a Celite plug, and the plug and precipitate were
washed with CH2Cl2 (2  50 mL). The combined washings were separated and the organic layers
were washed with brine (30 mL) and dried with anhydrous magnesium sulfate. The solution was sub-
sequently filtered and concentrated under reduced pressure to yield alkyne 3 as a yellow oil (88.8
mg, 0.612 mmol, 82%) (Li et al., 2013).
TLC (CH2Cl2): Rf: 0.35.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.03 (d, J = 7.8 Hz, 2H), 6.64 (d,
J = 7.7 Hz, 2H), 3.58 (s, 2H), 2.75 (t, J = 7.4 Hz, 2H), 2.45–2.42 (m, 2H), 1.99 (d, J = 1.5 Hz, 1H). 13C
NMR (CDCl3, 101 MHz, 25˚C): d 144.79, 130.51, 129.26, 115.22, 84.27, 68.82, 34.08, 20.99. IR
(neat, ATR): 3433, 3359, 3286, 3017, 2926, 2858, 2113, 1708, 1622, 1515, 1429, 1274, 1180, 1125,
1084, 822, 735, 629, 566. HRMS (EI+): m/z calcd. for [C10H11N]
+: 145.0892, found: 145.0882.
Synthesis of 4-(4-((4-(but-3-yn-1-yl)phenyl)diazenyl)phenyl)butanoic acid
(cFAAzo-4)
4-(4-Nitrosophenyl)butanoic acid was prepared by adding a solution of Oxone (510 mg, 1.67 mmol,
2.0 equiv.) in water (10 mL) to a stirring solution of 4-(4-aminophenyl)butyric acid (150 mg, 0.837
mmol, 1.0 equiv.) in CH2Cl2 (2.5 mL) at ambient temperature. The reaction mixture was stirred vigor-
ously for 4 hr at room temperature, whereupon 2 M HCl (10 mL) was added and the aqueous layer
was then extracted with CH2Cl2 (3  10 mL). The combined organic layers were washed with water
(10 mL) and brine (10 mL), dried with anhydrous magnesium sulfate, then filtered and concentrated
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under reduced pressure to afford 4-(4-nitrosophenyl)butanoic acid as a yellow powder, which was
taken directly to the next reaction (Priewisch and Ru¨ck-Braun, 2005).
4-(4-Nitrosophenyl)butanoic acid (110 mg, 0.569 mmol) and alkyne 3 (89 mg, 0.61 mmol) were
dissolved in AcOH (6 mL) and stirred at ambient temperature for 17 hr. Reaction progress was moni-
tored by TLC. The solvent was removed under reduced pressure, and the crude material purified by
flash column chromatography (10:89:1 fi 25:74:1 EtOAc/hexanes/AcOH) to afford cFAAzo-4 as a
yellow gum (36 mg, 0.11 mmol, 20%).
TLC (20:79:1 EtOAc/hexane/AcOH): Rf: 0.27.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.84 (dd,
J = 8.0, 5.5 Hz, 4H), 7.37 (d, J = 8.2 Hz, 2H), 7.32 (d, J = 8.2 Hz, 2H), 2.92 (t, J = 7.5 Hz, 2H), 2.75 (t,
J = 7.6 Hz, 2H), 2.54 (td, J = 7.4, 2.6 Hz, 2H), 2.41 (t, J = 7.3 Hz, 2H), 2.03–2.00 (m, 3H). 13C NMR
(CDCl3, 101 MHz, 25˚C): d 178.48, 151.53, 151.38, 144.63, 143.66, 129.33, 129.32, 123.07, 123.01,
83.56, 69.39, 35.01, 34.79, 33.18, 26.18, 20.54. IR (neat, ATR): 3272, 2952, 2854, 1693, 1601, 1516,
1412, 1344, 1282, 1216, 1154, 911, 850. HRMS (ESI+): m/z calcd. for [C20H22N2O2]
+: 321.1598,
found: 321.1594 ([M + H]+).
Synthesis of 4-(4-(4-(but-3-yn-1-yl)phenyl)diazenyl)phenyl)-N-((2S,3R,E) 1,3-
dihydroxyoctadec-4-en-2-yl)butanamide (caCer-1)
To a stirred solution of cFAAzo-4 (12.0 mg, 0.0371 mmol, 1.0 equiv.) in EtOAc (1.5 mL) was added
TBTU (12.0 mg, 0.0374 mmol, 1.0 equiv.) at ambient temperature. After stirring for 1 hr, D-erythro-
sphingosine (14.6 mg, 0.0487 mmol, 1.3 equiv.) was added to the solution, followed by Et3N (20.1
mL, 0.150 mmol, 4.0 equiv.). The reaction was continued for 15 hr, when progress was determined to
be complete via TLC analysis. Aqueous saturated NaHCO3 solution (3 mL) was added to the reaction
mixture, and the aqueous layer was separated and further extracted with EtOAc (2  5 mL). The
combined organic layers were washed with brine (5 mL), dried over anhydrous sodium sulfate, fil-
tered and concentrated under reduced pressure. The residue was purified by flash column chroma-
tography (75 fi 85% EtOAc in hexanes) to afford caCer-1 (14.8 mg, 0.0246 mmol, 66%) as an
orange powder.
TLC (80% EtOAc in hexane): Rf: 0.22.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.83 (t, J = 8.2 Hz,
4H), 7.34 (dd, J = 17.0, 8.5 Hz, 4H), 6.28 (d, J = 7.6 Hz, 1H), 5.81–5.75 (m, 1H), 5.55–5.49 (m, 1H),
4.30–4.28 (m, 1H), 3.97–3.89 (m, 2H), 3.68 (dd, J = 11.1, 3.2 Hz, 1H), 2.92 (t, J = 7.4 Hz, 2H), 2.74 (t,
J = 7.5 Hz, 2H), 2.54 (td, J = 7.5, 2.6 Hz, 2H), 2.28–2.24 (m, 2H), 2.05–1.99 (m, 5H), 1.34–1.23 (m,
24H), 0.89–0.86 (m, 3H). 13C NMR (CDCl3, 101 MHz, 25˚C): d 173.32, 151.47, 151.33, 144.87,
143.67, 134.42, 129.36, 129.31, 128.83, 123.03, 123.00, 83.53, 74.79, 69.39, 62.50, 54.45, 35.89,
35.16, 34.77, 32.43, 32.06, 29.83, 29.80, 29.77, 29.63, 29.51, 29.37, 29.25, 27.00, 22.84, 20.52,
14.28. IR (neat, ATR): 3294, 2919, 2850, 1646, 1603, 1547, 1498, 1466, 1417, 1378, 1302, 1271,
1223, 1201, 1154, 1102, 1056, 1025, 1013, 961, 920, 892, 850, 832, 720, 633, 571, 560. HRMS
(ESI+): m/z calcd. for [C38H56N3O3]
+: 602.4316, found: 602.4316 ([M + H]+). Melting point: 103–
105˚C.
Synthesis of 4-((4-(but-3-yn-1-yl)phenyl)diazenyl)benzoic acid (cFAAzo-1)
Methyl 4-nitrosobenzoate was prepared by adding a solution of Oxone (1.50 g, 4.91 mmol, 5.0
equiv.) in water (40 mL) to a stirred solution of 4-carboxymethyl aniline (150 mg, 0.992 mmol, 1.0
equiv.) in CH2Cl2 (10 mL). The reaction mixture was stirred vigorously for 4 hr at room temperature.
The reaction was quenched with 2 M HCl (50 mL) and then extracted with CH2Cl2 (3  50 mL). The
combined organic layers were washed with water and brine, dried with anhydrous magnesium sul-
fate, then filtered and concentrated under reduced pressure to afford methyl 4-nitrosobenzoate as a
yellow powder, which was used without further purification (Priewisch and Ru¨ck-Braun, 2005;
Nishioka et al., 2007).
Methyl 4-nitrosobenzoate (43 mg, 0.26 mmol, 1.5 equiv.) and alkyne 3 (25 mg, 0.17 mmol, 1.0
equiv.) were dissolved in AcOH (2 mL) and stirred at ambient temperature for 18 hr. Reaction prog-
ress was monitored by TLC. The reaction solvent was removed under reduced pressure. The crude
material was then eluted through a silica gel plug (25% EtOAc in hexanes) and the solvent removed
under reduced pressure to afford the product mixture as a yellow powder, which could more conve-
niently be purified after subsequent ester cleavage.
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The crude carbomethoxyaryl mixture was dissolved in MeOH (2 mL) and 2 M NaOH (0.4 mL) was
added. The reaction was stirred for 16 hr at ambient temperature and was then acidified by the
addition of 1 M HCl solution (1 mL). The mixture was extracted with EtOAc, then washed with water
and brine. The organic layer was dried with anhydrous magnesium sulfate, then filtered and concen-
trated under reduced pressure and the crude material was purified by flash column chromatography
(silica gel, 10:89:1 fi 25:74:1 EtOAc/hexane/AcOH) to afford cFAAzo-1 as a pale-yellow powder (16
mg, 0.057 mmol, 34% over two steps).
TLC (25:74:1 EtOAc/hexane/AcOH): Rf: 0.30.
1H NMR (acetone-d6, 400 MHz, 25˚C): d 8.26 (d,
J = 8.6 Hz, 2H), 8.02 (d, J = 8.6 Hz, 2H), 7.95 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 8.5 Hz, 2H), 2.97 (t,
J = 7.3 Hz, 2H), 2.59 (td, J = 7.4, 2.7 Hz, 2H), 2.41 (t, J = 2.7 Hz, 1H). 13C NMR (acetone-d6, 101
MHz, 25˚C): d 166.98, 155.97, 152.06, 146.21, 133.23, 131.65, 130.46, 123.88, 123.35, 83.99, 70.79,
35.26, 20.62. IR (neat, ATR): 3281, 2931, 2362, 1686, 1603, 1544, 1503, 1427, 1310, 1292, 1142,
1098, 1012, 946, 867, 835, 778, 692. HRMS (EI+): m/z calcd. for [C17H14N2O2]
+: 278.1055, found:
278.1047. Melting point: 235˚C (decomposed).
Synthesis of 4-(4-(but-3-yn-1-yl)phenyl)diazenyl-N-((2S,3R,E) 1,3-
dihydroxyoctadec-4-en-2-yl)benzamide (caCer-2)
To a stirred solution of cFAAzo-1 (4.2 mg, 0.015 mmol, 1.0 equiv.) in EtOAc/DMF (5:1, 0.6 mL) was
added HBTU (5.7 mg, 0.015 mmol,1.0 equiv.) under an inert atmosphere at ambient temperature.
After 1 hr, D-erythro-sphingosine (5.4 mg, 0.018 mmol, 1.2 equiv.) was added, followed by Et3N (6.3
mL, 0.045 mmol, 3.0 equiv.). The reaction was continued for 6.5 hr, when progress was determined
to be complete via TLC. The reaction was quenched by the addition of saturated NaHCO3 solution
(5 mL). The mixture was extracted with EtOAc (3  5 mL), and the combined organic layers were
washed with brine (5 mL), dried with anhydrous sodium sulfate, filtered and concentrated under
reduced pressure. The crude product was purified by flash column chromatography (60 fi 75%
EtOAc in pentane) to afford caCer-2 as an orange powder (7.0 mg, 0.013 mmol, 83%).
TLC (75% EtOAc in hexane): Rf: 0.43.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.92 (d, J = 1.0 Hz,
4H), 7.88 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 7.6 Hz, 1H), 5.87–5.80 (m, 1H),
5.60 (dd, J = 15.4, 6.3 Hz, 1H), 4.47 (t, J = 4.7 Hz, 1H), 4.14–4.07 (m, 2H), 3.83 (dd, J = 11.2, 3.1 Hz,
1H), 2.93 (d, J = 14.8 Hz, 2H), 2.54 (td, J = 7.4, 2.6 Hz, 2H), 2.06 (dt, J = 11.0, 5.3 Hz, 2H), 2.01 (t,
J = 4.1 Hz, 1H), 1.37–1.34 (m, 2H), 1.23 (s, 22H), 0.87 (t, J = 6.9 Hz, 3H). 13C NMR (CDCl3, 101
MHz, 25˚C): d 167.19, 154.59, 151.39, 144.62, 135.85, 134.71, 129.45, 128.88, 128.21, 123.39,
123.03, 83.43, 75.02, 69.48, 62.52, 54.88, 34.81, 32.46, 32.08, 29.85, 29.84, 29.81, 29.76, 29.64,
29.52, 29.36, 29.27, 22.85, 20.47, 14.29. IR (neat, ATR): 3295, 2921, 2851, 1637, 1541, 1493, 1467,
1341, 1297, 1055, 1014, 964, 858. HRMS (ESI+): m/z calcd. for [C35H50N3O3]
+: 560.3847, found:
560.3851 ([M + H]+). Melting point: 120˚C.
Synthesis of pentadec-7-yn-1-ol (S1)
A solution of 1-nonyne (0.500 g, 4.03 mmol, 1.0 equiv.) in THF (30 mL) and HMPA (8 mL) was cooled
to –78˚C and treated with a solution of n-BuLi (2.48 M in hexanes, 3.41 mL, 8.45 mmol, 2.1 equiv.).
The opaque, black solution was warmed to 0˚C and stirred for 1 hr, then cooled once more to –78˚C
whereupon 6-bromohexanoic acid (0.785 g, 4.03 mmol, 1.0 equiv.) in THF (6 mL) was added drop-
wise. The reaction mixture was allowed to warm to ambient temperature and stirred for 48 hr, where
the solution became clear and pale brown. Saturated aqueous ammonium chloride solution (25 mL)
was then added to the solution and the aqueous layer was separated and extracted with EtOAc
(3  30 mL). The combined organic layers were washed with distilled water (2  20 mL), saturated
aqueous lithium chloride solution (2  20 mL) and brine (20 mL), dried over anhydrous sodium sul-
fate, filtered and concentrated. The pale orange oil was used directly in the next procedure without
purification.
The crude oil from the previous step was dissolved in THF (5 mL) and was added dropwise to a
suspension of lithium aluminum hydride (229 mg, 6.05 mmol, 1.5 equiv.) cooled to 0˚C with an ice
bath. The mixture was allowed to warm to room temperature and stirred for 1.5 hr, where thin layer
chromatography analysis indicated complete conversion. The mixture was cooled with an ice bath
and carefully quenched with distilled water (5 mL) followed by 2 M aqueous sodium hydroxide solu-
tion (10 mL). The aqueous phase was extracted with Et2O (3  30 mL) and the combined organic
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layers were washed with saturated aqueous ammonium chloride (30 mL) and brine (20 mL), dried
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The crude oil was
purified by flash column chromatography (15% EtOAc in pentane) to yield pentadec-7-yn-1-ol S1
(127 mg, 0.567 mmol, 14% over two steps) as a colorless oil.
TLC (30% EtOAc in pentane): Rf=0.62.
1H NMR (CDCl3, 400 MHz, 25˚C): d 3.64 (t, J = 6.6 Hz,
2H), 2.19–2.08 (m, 4H), 1.58 (p, J = 6.7 Hz, 2H), 1.53–1.18 (m, 17H), 0.88 (t, J = 6.8 Hz, 3H). 13C
NMR (CDCl3, 100 MHz, 25˚C): d 80.55, 80.16, 63.14, 32.83, 31.93, 29.31, 29.21, 28.99, 28.99,
28.74, 25.43, 22.79, 18.90, 18.84, 14.26. IR (neat, ATR): 3328, 2927, 2856, 1460, 1434, 1378, 1332,
1073, 1054, 1030, 724. MS (FAB+): m/z calcd. for [C16H17N2O]
+: 225.4, found: 225.4 ([M + H]+).
Synthesis of pentadec-14-yn-1-ol (S2)
Sodium hydride (60% in mineral oil, 149 mg, 3.74 mmol, 8.0 equiv.) was added in one portion to 1,3-
diaminopropane (5 mL) at room temperature. The mixture was heated to 70˚C and stirred for 1 hr,
where it became opaque and brown, then cooled to room temperature. Pentadec-7-yn-1-ol S1 (105
mg, 0.467 mg, 1.0 equiv.) in 1,3-diaminopropane (2 mL) was added to the vessel and the mixture
was heated to 60˚C and stirred for 19 hr. The reaction mixture was allowed to cool to room tempera-
ture and diluted with Et2O (10 mL). Distilled water (10 mL) was then carefully added and the aqueous
layer was separated and further extracted with Et2O (3  10 mL). The combined organic layers were
washed with distilled water (10 mL), 1 M HCl (10 mL) and brine (10 mL), dried over anhydrous
sodium sulfate, filtered and concentrated. The crude residue was purified by flash column chroma-
tography (15% EtOAc in pentane) to yield pentadec-14-yn-1-ol S2 (70.3 mg, 0.313 mmol, 67%) as a
white solid. The 1H NMR spectrum is in agreement with that previously reported (Oppolzer et al.,
2001).
TLC (20% EtOAc in pentane): Rf=0.44.
1H NMR (CDCl3, 400 MHz, 25˚C): d 3.61 (t, J = 6.7 Hz,
2H), 2.16 (td, J = 7.1, 2.7 Hz, 2H), 1.92 (t, J = 2.7 Hz, 1H), 1.59–1.46 (m, 5H), 1.40–1.22 (m, 18H).
Synthesis of pentadec-14-ynoic acid (4)
A chromic acid oxidizing solution was prepared according to literature (Eisenbraun, 1965). Chro-
mium trioxide (67.0 g, 670 mmol) was dissolved in distilled water (125 mL) and the solution was
cooled to 0˚C. Concentrated sulfuric acid (58 mL) was added to the solution and the mixture was
allowed to warm to room temperature. Distilled water was added to bring the total volume of the
solution to 225 mL, making a ~ 3 M aqueous solution of chromic acid oxidizing solution. The chromic
acid solution (0.149 mL, 0.446 mmol, 1.5 eq.) was added dropwise to a solution of pentadec-14-yn-
1-ol S2 (66.7 mg, 0.297 mmol, 1.0 equiv.) in acetone (2.0 mL) at 0˚C. The mixture was stirred for 2 hr
at 0˚C until TLC analysis indicated complete conversion. The solution was filtered through a pad of
Celite and the vessel and pad were washed with Et2O (50 mL). The filtrate was washed with distilled
water (20 mL) and brine (20 mL) and concentrated under reduced pressure. The crude residue was
purified by flash column chromatography (10 fi 30% EtOAc in pentane) to yield pentadec-14-ynoic
acid 4 (58.1 mg, 0.244 mmol, 82%) as a waxy white solid. The 1H NMR spectrum is in agreement
with that previously reported (Seike et al., 2006).
TLC (20% EtOAc in pentane): Rf=0.24.
1H NMR (CDCl3, 400 MHz, 25˚C): d 11.24 (broad s, 1H),
2.34 (t, J = 7.5 Hz, 2H), 2.18 (td, J = 7.1, 2.7 Hz, 2H), 1.94 (t, J = 2.6 Hz, 1H), 1.62 (q, J = 7.2 Hz, 2H),
1.52 (p, J = 7.2 Hz, 2H), 1.43–1.19 (m, 16H).
Synthesis of 4-((4-propylphenyl)diazenyl)benzyl alcohol (5)
A solution of 4-propylaniline (2.50 g, 18.5 mmol, 2.1 equiv.) in CH2Cl2 (80 mL) was treated with
Oxone (22.7 g, 74.0 mmol, 8.5 equiv.) in distilled water (100 mL) at room temperature and the
biphasic mixture was stirred vigorously at room temperature for 20 hr. The aqueous phase was sepa-
rated and further extracted with CH2Cl2 (2  60 mL). The combined organic phases were washed
with 1 M hydrochloric acid solution (75 mL), saturated aqueous sodium bicarbonate solution (75 mL)
and brine (75 mL), then dried over anhydrous sodium sulfate, filtered and concentrated under
reduced pressure. The crude residue was purified by flash column chromatography (CH2Cl2), and the
bright green fractions were collected, combined and concentrated to afford 4-propylnitrosobenzene
as a clear green oil, which was taken directly to the next procedure.
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The nitrosobenzene was redissolved in glacial acetic acid (75 mL) and 4-aminobenzyl alcohol (1.08
g, 8.74 mmol, 1.0 equiv.) in acetic acid (25 mL) was added to the solution at room temperature. The
mixture was stirred vigorously for 72 hr at room temperature, then concentrated under reduced
pressure and azeotroped twice with toluene (50 mL). The crude orange solid was purified by flash
column chromatography (20 fi 25% EtOAc in pentane) to afford 4-((4-propylphenyl)diazenyl)benzyl
alcohol 5 (911 mg, 3.58 mmol, 41% yield) as an orange solid.
TLC (30% EtOAc in pentane): Rf=0.43.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.90 (d, J = 8.4 Hz,
2H), 7.85 (d, J = 8.4 Hz, 2H), 7.50 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 4.77 (s, 2H), 2.67 (t,
J = 7.5 Hz, 2H), 1.89 (broad s, 1H), 1.70 (p, J = 7.5 Hz, 2H), 0.97 (t, J = 7.5 Hz, 3H).13C NMR (CDCl3,
100 MHz, 25˚C): d 152.32, 151.05, 146.49, 143.62, 129.31, 127.56, 123.07, 122.96, 65.03, 38.08,
24.55, 13.94. IR (neat, ATR): 3332, 2958, 2930, 2869, 1661, 1585, 1499, 1449, 1417, 1340, 1303,
1222, 1026, 1010, 852, 832. HRMS (ESI+): m/z calcd. for [C16H19N2O]
+: 255.1492, found: 255.1491
([M + H]+). Melting point: 138˚C.
Synthesis of 4-((4-propylphenyl)diazenyl)benzaldehyde (6)
A solution of 4-((4-propylphenyl)diazenyl)benzyl alcohol 5 (302 mg, 1.19 mmol, 1.0 equiv.) in CH2Cl2
(12 mL) was treated with Dess-Martin periodinane (655 mg, 1.55 mmol, 1.3 equiv.) at room tempera-
ture. The reaction mixture was left to stir for 45 min and a mixture of saturated aqueous sodium
bicarbonate solution and saturated aqueous sodium thiosulfate solution (1:1, 20 mL) was then
added. The biphasic mixture was stirred for 30 min, then the aqueous phase was separated and
extracted with CH2Cl2 (2  20 mL). The combined organic layers were washed with saturated aque-
ous sodium bicarbonate solution (30 mL), dried over anhydrous sodium sulfate, filtered and concen-
trated under reduced pressure. The crude residue was purified by flash column chromatography (3
fi 4% EtOAc in pentane) to afford 4-((4-propylphenyl)diazenyl)benzaldehyde 6 (282 mg, 1.12 mmol,
94%) as a red crystalline solid.
TLC (30% EtOAc in pentane): Rf=0.43.
1H NMR (CDCl3, 400 MHz, 25˚C): d 10.07 (s, 1H), 8.00
(s, 4H), 7.88 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 2.66 (t, J = 7.6 Hz, 2H), 1.69 (p, J = 7.5 Hz,
2H), 0.97 (t, J = 7.4 Hz, 3H).13C NMR (CDCl3, 100 MHz, 25˚C): d 191.64, 156.01, 150.91, 147.57,
137.24, 130.70, 129.34, 123.36, 123.25, 38.04, 24.40, 13.88. IR (neat, ATR): 3023, 2956, 2929, 2845,
2739, 1696, 1597, 1581, 1498, 1460, 1416, 1378, 1316, 1304, 1289, 1197, 1183, 1148, 1129, 1112,
1090, 1003, 908, 847, 831, 811, 793, 75, 729, 663. HRMS (ESI+): m/z calcd. for [C16H19N2O]
+:
253.1335, found: 253.1336 ([M + H]+). Melting point: 107˚C.
Synthesis of 1-(4-propylphenyl) 2-(4-vinylphenyl)diazene (7)
A suspension of methyltriphenylphosphonium bromide (439 mg, 1.23 mmol, 1.1 equiv.) in THF (12
mL) at 0˚C was treated with a solution of n-BuLi (2.48 m in hexanes, 0.496 mL, 1.23 mmol, 1.1
equiv.). The resulting bright yellow suspension was stirred for 20 min at 0˚C and a solution of 4-((4-
propylphenyl)diazenyl)benzaldehyde 6 (282 mg, 1.12 mmol, 1.0 equiv.) in THF (5 mL) was added
dropwise. The mixture was allowed to warm to room temperature and stirred for 1 hr. Saturated
aqueous ammonium chloride solution (20 mL) was added and the aqueous phase was extracted with
CH2Cl2 (3  20 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered
and concentrated under reduced pressure. The residue was purified by flash column chromatogra-
phy (dry loading with 1 g silica gel, 0 fi 3% Et2O in pentane) to yield 1-(4-propylphenyl) 2-(4-vinyl-
phenyl)diazene 7 (237 mg, 0.946 mmol, 84%) as a crystalline orange solid.
TLC (30% EtOAc in pentane): Rf=0.43.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.89 (d, J = 8.5 Hz,
2H), 7.86 (d, J = 8.4 Hz, 2H), 7.55 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.4 Hz, 2H), 6.79 (dd, J = 17.6,
10.9 Hz, 1H), 5.87 (d, J = 17.6 Hz, 1H), 5.36 (d, J = 10.9 Hz, 1H), 2.68 (t, J = 7.5 Hz, 2H), 1.70 (h,
J = 7.5 Hz, 2H), 0.98 (t, J = 7.5 Hz, 3H). 13C NMR (CDCl3, 100 MHz, 25˚C): d 152.31, 151.17,
146.42, 140.00, 136.33, 129.30, 127.03, 123.21, 122.96, 115.55, 38.09, 24.56, 13.95. IR (neat, ATR):
3045, 2958, 2929, 2870, 1626, 1598, 1497, 1454, 1414, 1402, 1303, 1287, 1226, 1155, 1109, 1011,
988, 908, 848, 802, 748. HRMS (ESI+): m/z calcd. for [C17H19N2]
+: 251.1543, found: 251.1543
([M + H]+). Melting point: 37˚C.
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Synthesis of 4-iodo-4’-methylazobenzene (S3)
4-Iodo-4’-methylazobenzene was synthesized following a modified procedure of Strueben et al.
(2014). A solution of p-toluidine (2.50 g, 24.3 mmol, 1.0 equiv.) in CH2Cl2 (80 mL) was treated with
Oxone (29.8 g, 97.1 mmol, 4.1 equiv.) in distilled water (120 mL) at room temperature and the
biphasic mixture was stirred vigorously at room temperature for 18 hr. The aqueous phase was sepa-
rated and further extracted with CH2Cl2 (2  50 mL). The combined organic phases washed with 1
M hydrochloric acid solution (80 mL), saturated aqueous sodium bicarbonate solution (80 mL) and
brine (80 mL), then dried over anhydrous sodium sulfate, filtered and concentrated under reduced
pressure. The crude residue was purified by flash column chromatography (CH2Cl2), and the bright
green fractions were collected, combined and concentrated to afford a clear green oil. The oil was
redissolved in CH2Cl2 (20 mL) and acetic acid (30 mL) and 4-iodoaniline (5.13 g, 23.4 mmol, 1.0
equiv.) was added to the solution. The mixture was stirred for 15 hr at room temperature, during
which an orange-yellow crystalline solid precipitated. The mixture was concentrated under reduced
pressure, suspended in ice-cold ethanol (30 mL) and filtered. The recovered crystals were washed
with ice-cold ethanol (30 mL) and dried to afford 4-iodo-4’-methylazobenzene S3 (3.35 g, 10.4
mmol, 45% yield) as an orange-yellow crystalline solid. The 1H NMR and 13C NMR spectra are in
agreement with those previously reported (Strueben et al., 2014).
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.85 (d, J = 8.5 Hz, 2H), 7.82 (d, J = 8.5 Hz, 2H), 7.64 (d,
J = 8.5 Hz, 2H), 7.32 (d, J = 8.5 Hz, 3H), 2.44 (s, 3H). 13C NMR (CDCl3, 100 MHz, 25˚C): d 152.13,
150.70, 142.17, 138.43, 129.96, 124.51, 123.12, 97.37, 21.72.
Synthesis of 3-(4-(p-tolyldiazenyl)phenyl)propanal (S4)
1-(4-Iodophenyl) 2-(p-tolyl)diazene (3.34 g, 10.4 mmol, 1.0 equiv.) was suspended in DMF (12 mL)
and toluene (12 mL) at room temperature and tetrabutylammonium chloride (2.89 g, 10.4 mmol, 1.0
equiv.), sodium bicarbonate (2.18 g, 26.0 mmol, 2.5 equiv.) and allyl alcohol (0.906 g, 15.6 mmol, 1.5
equiv.) were added sequentially to the stirring mixture. The orange suspension was stirred for 10
min at room temperature, whereupon PdCl2 (0.369 mg, 2.08 mmol, 0.20 equiv.) was added to the
flask. The bright red suspension was warmed to 45˚C and stirred for 2.5 hr, then cooled back to
room temperature and stirred for 48 hr. The reaction mixture was then diluted with EtOAc (125 mL)
and washed successively with 1 M aqueous hydrochloric acid solution (50 mL), distilled water (4  50
mL) and brine (50 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and con-
centrated. The crude residue was purified by flash column chromatography (6 fi 10% EtOAc in pen-
tane) to yield 3-(4-(p-tolyldiazenyl)phenyl)propanal (2.28 g, 9.07 mmol, 87%) as a crystalline orange
solid.
TLC (10% EtOAc in pentane): Rf=0.36.
1H NMR (CDCl3, 400 MHz, 25˚C): d 9.82 (s, 1H), 7.85 (d,
J = 7.5 Hz, 2H), 7.83 (d, J = 7.5 Hz, 2H), 7.33 (d, J = 7.5 Hz, 2H), 7.31 (d, J = 7.5 Hz, 2H), 3.02 (t,
J = 7.5 Hz, 2H), 2.81 (t, J = 7.5 Hz, 2H), 2.43 (s, 3H). 13C NMR (CDCl3, 100 MHz, 25˚C): d 201.18,
151.36, 150.78, 143.48, 141.52, 129.80, 129.06, 123.06, 122.85, 45.08, 27.97, 21.57. IR (neat, ATR):
3022, 2921, 2832, 2730, 1716, 1600, 1497, 1448, 1416, 1390, 1356, 1302, 1221, 1210, 1153, 1111,
1061, 1038, 1011, 904, 843, 822, 728, 705, 682. HRMS (ESI+): m/z calcd. for [C16H17N2O]
+:
253.1335, found: 253.1336 ([M + H]+). Melting point: 78˚C.
Synthesis of 1-(4-(but-3-en-1-yl)phenyl) 2-(p-tolyl)diazene (S5)
A suspension of methyltriphenylphosphonium bromide (3.87 g, 10.8 mmol, 1.2 equiv.) in THF (50
mL) at –78˚C was treated with a solution of n-BuLi (2.48 m in hexanes, 4.37 mL, 10.8 mmol, 1.2
equiv.). The resulting bright yellow suspension was warmed to 0˚C for 20 min, then cooled once
more to –78˚C. 3-(4-(p-Tolyldiazenyl)phenyl)propanal (2.28 g, 9.02 mmol, 1.0 equiv.) in THF (10 mL)
was added dropwise and the mixture was allowed to warm to room temperature and stirred for 15
hr. Saturated aqueous ammonium chloride solution (60 mL) was added and the aqueous phase was
separated and further extracted with CH2Cl2 (2  80 mL). The combined organic layers were dried
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was
purified by flash column chromatography (dry loading, 1 fi 2% EtOAc in pentane) to yield 1-(4-(but-
3-en-1-yl)phenyl) 2-(p-tolyl)diazene (2.06 g, 8.22 mmol, 91%) as a crystalline orange solid.
TLC (2% EtOAc in pentane): Rf=0.30.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.78 (d, J = 8.2 Hz,
2H), 7.76 (d, J = 7.5 Hz, 2H), 7.25 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 7.5 Hz, 2H), 5.80 (ddt, J = 16.9,
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10.2, 6.6 Hz, 1H), 4.99 (dd, J = 16.9, 1.7 Hz, 1H), 4.94 (dd, J = 10.2, 1.7 Hz, 1H), 2.72 (t, J = 7.5 Hz,
2H), 2.36 (m, 5H). 13C NMR (CDCl3, 100 MHz, 25˚C): d 151.20, 150.92, 145.14, 141.35, 137.80,
129.82, 129.23, 122.88, 122.86, 115.38, 35.42, 35.37, 21.61. IR (neat, ATR): 3074, 3054, 3024, 2977,
2922, 2857, 1640, 1601, 1580, 1497, 1440, 1415, 1302, 1224, 1209, 1155, 1105, 1012, 996, 950, 907,
837, 823, 708, 643. HRMS (ESI+): m/z calcd. for [C17H19N2]
+: 251.1543, found: 251.1542 ([M + H]+).
Melting point: 57˚C.
Synthesis of N-Boc-(R) 1-((S) 2,2-dimethyloxazolidin-4-yl)prop-2-en-1-ol (8)
Vinyl magnesium bromide (1.0 M in THF, 22.7 mL, 22.7 mmol, 2.0 equiv.) was added over 30 min via
drop funnel to a solution of (S) 1,1-dimethylethyl 4-formyl-2,2-dimethyloxazolidine-3-carboxylate
(2.61 g, 11.4 mmol, 1.0 equiv.) in THF (50 mL) at –78˚C. The reaction mixture was stirred for 2 hr at –
78˚C until TLC analysis indicated complete conversion, and saturated aqueous ammonium chloride
solution (40 mL) was added at this temperature. After warming to room temperature, the aqueous
layer was separated and extracted with EtOAc (3  70 mL). The combined organic layers were dried
over anhydrous sodium sulfate, filtered and concentrated. The crude residue was purified by flash
column chromatography (15% EtOAc in pentane) to afford N-Boc-(R) 1-((S) 2,2-dimethyloxazolidin-
4-yl)prop-2-en-1-ol 8 (2.33 g, 9.07 mmol, 80%) as a colorless oil. High-temperature 1H NMR analysis
indicates a 5.2:1 anti/syn mixture of diastereomers, consistent with previous literature
results (Ojima and Vidal, 1998). Further purification of the mixture by careful column chromatogra-
phy (10% EtOAc in pentane) yielded the pure anti diastereomer.
TLC (20% EtOAc in pentane): Rf=0.35.
1H NMR (toluene-d8, 400 MHz, 90˚C): d 5.81 (ddd,
J = 16.7, 10.5, 5.2 Hz, 1H), 5.31 (dt, J = 16.7, 1.8 Hz, 1H), 5.06 (d, J = 10.5 Hz, 1H), 4.26 (broad s,
1H), 3.87 (m, 1H), 3.77 (m, 1H), 3.66 (dd, J = 9.0, 6.8 Hz, 1H), 1.58 (s, 3H), 1.43 (s, 3H), 1.38 (s, 9H).
13C NMR (toluene-d8, 100 MHz, 90˚C): d 153.39, 138.68, 115.44, 94.68, 80.27, 73.87, 64.81, 62.47,
28.49, 26.82, 24.43. IR (neat, ATR): 3461, 2978, 2936, 2879, 1694, 1478, 1456, 1377, 1365, 1255,
1206, 1170, 1095, 1049, 989, 923, 848, 807, 767. HRMS (ESI+): m/z calcd. for [C13H24NO4]
+:
258.1700, found: 258.1699 ([M + H]+).
Synthesis of N-Boc-(R,E) 1-((S) 2,2-dimethyloxazolidin-4-yl) 3-((4-(4-
propylphenyl)diazenyl)phenyl)prop-2-en-1-ol (9)
Hoyveda-Grubbs 2nd generation catalyst (29.6 mg, 0.0472 mmol, 0.10 equiv.) was added to a solu-
tion of allyl alcohol 8 (121 mg, 0.472 mmol, 1.0 equiv.) and olefin 7 (236 mg, 0.944 mmol, 2.0 equiv.)
in degassed CH2Cl2 (6 mL) at room temperature. The deep red mixture was heated to 45˚C and
stirred for 21 hr. The mixture was cooled to room temperature and, without concentrating, was
loaded on an equilibrated silica gel column and purified by flash column chromatography (15% to
25% EtOAc in pentane). The combined fractions contained traces of remnant catalyst, and the prod-
uct was purified a second time by flash column chromatography (15 fi 25% EtOAc in pentane) to
yield 9 (71.1 mg, 0.148 mmol, 31%) as a dark orange gum.
TLC (20% EtOAc in pentane): Rf=0.32.
1H NMR (toluene-d8, 400 MHz, 90˚C): d 7.90 (d, J = 8.3
Hz, 2H), 7.88 (d, J = 8.3 Hz, 2H), 7.35 (d, J = 8.4 Hz, 2H), 7.07 (d, J = 8.3 Hz, 2H), 6.68 (dd, J = 15.8,
1.5 Hz, 1H), 6.26 (dd, J = 15.8, 5.6 Hz, 1H), 4.37 (m, 1H), 3.98 (m, 1H), 3.81 (m, 1H), 3.70 (dd,
J = 9.1, 6.7 Hz, 1H), 2.43 (t, J = 7.3, 2H), 1.56 (s, 3H), 1.52 (q, J = 7.3, 2H), 1.41 (s, 3H), 1.32 (s, 9H),
0.84 (t, J = 7.3 Hz, 3H). 13C NMR (toluene-d8, 100 MHz, 90˚C): d 153.79, 152.91, 152.14, 146.11,
140.24, 131.86, 130.52, 129.35, 127.55, 123.72, 123.49, 94.78, 80.53, 74.33, 65.21, 62.93, 38.27,
28.46, 27.02, 24.51, 13.81. IR (neat, ATR): 3426, 2976, 2933, 2873, 1693, 1600, 1497. 1477, 1455,
1389, 1376, 1366, 1255, 1205, 1156, 1100, 1068, 1050, 967, 921, 864, 847, 768, 733. HRMS (ESI+):
m/z calcd. for [C28H38N3O4]
+: 480.2857, found: 480.2860 ([M + H]+).
Synthesis of (2S,3R,E) 2-amino-5-(4-((4-propylphenyl)diazenyl)phenyl) pent-
4-ene-1,3-diol (aSph-1)
(R,E) 1-((S) 2,2-dimethyloxazolidin-4-yl) 6-(4-(p-tolyldiazenyl)phenyl)hex-2-en-1-ol 9 (23.9 mg,
0.0498 mmol, 1.0 equiv.) was dissolved in THF (1.25 mL) and the solution was cooled to 0˚C with an
ice bath. 2 M hydrochloric acid (0.50 mL) was added dropwise and the reaction mixture was heated
to 60˚C. After stirring for 3 hr, the solution was cooled to ambient temperature and saturated
sodium carbonate solution (5 mL) was added. The aqueous phase was extracted with CH2Cl2 (3  10
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mL) and the combined organic layers were dried over anhydrous sodium sulfate, filtered and concen-
trated under reduced pressure. The crude orange solid was purified by flash column chromatogra-
phy (5/94.5/0.5 fi 10/89/1 MeOH/CH2Cl2/aqueous ammonium hydroxide solution) to afford aSph-1
(13.1 mg, 0.0386 mmol, 77%) as an orange solid.
TLC (40% acetone in toluene): Rf=0.14.
1H NMR (methanol-d4, 400 MHz, 25˚C): d 7.77 (d,
J = 8.6 Hz, 2H), 7.73 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.6 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 6.66 (d,
J = 15.9 Hz, 1H), 6.38 (dd, J = 15.9, 6.8 Hz, 1H), 4.19 (t, J = 5.8 Hz, 1H), 3.65 (dd, J = 10.9, 4.6 Hz,
1H), 3.48 (dd, J = 10.9, 6.9 Hz, 1H), 2.85 (q, J = 5.7 Hz, 1H), 2.58 (d, J = 7.5 Hz, 2H), 1.60 (h, J = 7.4
Hz, 2H), 0.88 (t, J = 7.4 Hz, 3H).13C NMR (methanol-d4, 100 MHz, 25˚C): d 153.28, 152.36, 147.76,
141.00, 132.46, 132.26, 130.31, 128.38, 124.10, 123.82, 74.80, 64.24, 58.28, 38.89, 25.61, 14.10. IR
(neat, ATR): 3045, 2958, 2929, 2870, 1626, 1598, 1497, 1454, 1414, 1402, 1303, 1287, 1226, 1155,
1109, 1011, 988, 908, 848, 802, 748. HRMS (ESI+): m/z calcd. for [C20H26N3O2]
+: 340.2020, found:
340.2020 ([M + H]+). Melting point: 135˚C.
Synthesis of N-((2S,3R,E) 1,3-dihydroxy-5-(4-((4-propylphenyl) diazenyl)
phenyl)pent-4-en-2-yl)pentadec-14-ynamide (caCer-3)
aSph-1 (7.9 mg, 0.023 mmol, 1.0 equiv.) and pentadec-14-ynoic acid 4 (6.1 mg, 0.026 mmol, 1.1
equiv.) were dissolved in CH2Cl2 (0.8 mL) and the solution was cooled to 0˚C with an ice bath. Diiso-
propylethylamine (12.2 mL, 0.0698 mmol, 3.0 equiv.), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (7.6 mg, 0.040 mmol, 1.7 equiv.) and 1-hydroxybenzotriazole hydrate (6.8 mg, 0.044
mmol, 1.9 equiv.) were added sequentially to the flask, and the mixture was allowed warm to room
temperature and was stirred for 20 hr. Saturated aqueous sodium bicarbonate solution (5 mL) was
then added to the mixture. The aqueous layer was separated and extracted with CH2Cl2 (3  5 mL).
The combined organic layers were washed with 1 M hydrochloric acid (5 mL) and brine (5 mL), dried
over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was
purified by flash column chromatography (2 fi 4% MeOH in CH2Cl2) to afford caCer-3 (11.0 mg,
0.0197 mmol, 85%) as an orange solid.
Note
Due to initially proceeding with a mixture of epimers from compound 8, our first synthesis of caCer-
3 produced an inseparable 7.3:1 mixture of erythro/threo ceramide by 1H NMR analysis and biologi-
cal assays were conducted with this mixture. The procedures reported here are from a second syn-
thesis conducted with anti-8 to yield pure erythro-caCer-3.
TLC (90% EtOAc in pentane): Rf=0.36.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.86 (d, J = 8.5 Hz,
2H), 7.83 (d, J = 8.3 Hz, 2H), 7.50 (d, J = 8.5 Hz, 2H), 7.31 (d, J = 8.3 Hz, 2H), 6.77 (d, J = 16.1 Hz,
1H), 6.38 (dd, J = 16.1, 5.7 Hz, 1H), 6.37 (s, 1H), 4.59 (t, J = 4.0 Hz, 1H), 4.05 (m, 2H), 3.78 (m, 1H),
2.66 (t, J = 7.5 Hz, 2H), 2.24 (m, 2H), 2.16 (td, J = 7.1, 2.6 Hz, 2H), 1.94 (t, J = 2.6 Hz, 1H), 1.66 (m,
4H), 1.50 (p, J = 7.3 Hz, 2H) 1.41–1.15 (m, 18H), 0.97 (t, J = 7.3 Hz, 3H). 13C NMR (CDCl3, 100 MHz,
25˚C): d 174.30, 152.30, 151.11, 146.52, 138.71, 131.21, 130.19, 129.31, 127.38, 123.33, 122.99,
84.99, 74.62, 68.19, 62.52, 54.62, 38.09, 36.99, 29.74, 29.71, 29.64, 29.61, 29.52, 29.43, 29.25,
28.90, 28.62, 25.94, 24.55, 18.54, 13.95. IR (neat, ATR): 3296, 2922, 2850, 1645, 1600, 1547, 1467,
1440, 1302, 1257, 1155, 1116, 1065, 1002, 964, 862, 825, 724, 696. HRMS (ESI+): m/z calcd. for
[C35H50N3O3]
+: 560.3847, found: 560.3862 ([M + H]+). Melting point: 133˚C.
Synthesis of N-Boc-(R,E) 1-((S) 2,2-dimethyloxazolidin-4-yl) 6-(4-(p-
tolyldiazenyl)phenyl)hex-2-en-1-ol (S6)
Hoyveda-Grubbs catalyst, 2nd generation (63.8 mg, 0.102 mmol, 0.10 equiv.) was added to a solu-
tion of allyl alcohol S5 (262 mg, 1.02 mmol, 1.0 equiv.) and 1-(4-(but-3-en-1-yl)phenyl) 2-(p-tolyl)dia-
zene (510 mg, 2.04 mmol, 2.0 equiv.) in degassed CH2Cl2 (8 mL) at room temperature. The deep
red mixture was heated to 45˚C and stirred for 16 hr. The mixture was cooled to ambient tempera-
ture and, without concentrating, was loaded on an equilibrated silica gel column and purified by
flash column chromatography (15 fi 25% EtOAc in pentane). The combined fractions contained
traces of remnant catalyst, and the product was purified a second time by flash column chromatog-
raphy (15 fi 25% EtOAc in pentane) to yield S6 (223 mg, 0.450 mmol, 44%) as an orange gum.
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TLC (20% EtOAc in pentane): Rf=0.35.
1H NMR (toluene-d8, 400 MHz, 90˚C): d 7.89 (d, J = 8.1
Hz, 2H), 7.86 (d, J = 8.1 Hz, 2H), 7.08 (m, 4H), 5.72 (dt, J = 13.3, 6.5 Hz, 1H), 5.49 (dd, J = 15.4, 5.6
Hz, 1H), 4.26 (broad s, 1H), 3.87 (m, 1H), 3.77 (m, 1H), 3.66 (dd, J = 9.0, 6.8 Hz, 1H), 2.62 (t, J = 7.7
Hz, 2H), 2.30 (q, J = 7.3 Hz, 2H), 2.15 (s, 3H), 1.58 (s, 3H), 1.43 (s, 3H), 1.38 (s, 9H). 13C NMR (tolu-
ene-d8, 100 MHz, 90˚C): 129.94, 129.37, 123.45, 123.38, 94.71, 80.24, 73.64, 64.92, 62.81, 35.99,
34.20, 28.60, 26.94, 24.55, 21.22. IR (neat, ATR): 3448, 2978, 2933, 1694, 1602, 1498, 1478, 1454,
1388, 1376, 1365, 1255, 1206, 1156, 1101, 1067, 1014, 968, 912, 842, 768, 733. HRMS (ESI+): m/z
calcd. for [C28H38N3O4]
+: 480.2857, found: 480.2873 ([M + H]+).
Synthesis of (2S,3R,E) 2-amino-7-(4-(p-tolyldiazenyl)phenyl)hept-4-ene-1,3-
diol (aSph-2)
2 M Hydrochloric acid solution (2 mL) was added dropwise to a solution of S6 (94.2 mg, 0.196
mmol, 1.0 equiv.) in THF (4 mL) at room temperature and the reaction mixture was heated to 60˚C
for 3 hr. The solution was then basified to pH 10 with 2 M sodium hydroxide solution (2.4 mL) and
the aqueous mixture was extracted with CH2Cl2 (3  10 mL). The combined organic layers were
washed with brine (10 mL), dried over anhydrous sodium sulfate, filtered and concentrated under
reduced pressure. The crude orange solid was purified by flash column chromatography (5/94.5/0.5
fi 10/89/1 MeOH/CH2Cl2/aqueous 25% ammonium hydroxide solution) to afford aSph-2 (55.5 mg,
0.164 mmol, 84%) as an orange solid.
TLC (40% acetone in toluene): Rf=0.14.
1H NMR (methanol-d4, 400 MHz, 25˚C): d 7.79 (d,
J = 8.1 Hz, 2H), 7.76 (d, J = 7.9 Hz, 2H), 7.34 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 7.9 Hz, 2H), 5.76 (dt,
J = 15.4, 6.8 Hz, 1H), 5.47 (dd, J = 15.4, 6.8 Hz, 1H), 3.95 (t, J = 6.7 Hz, 1H), 3.59 (dd, J = 11.2, 4.1
Hz, 1H), 3.43 (dd, J = 11.2, 6.9 Hz, 1H), 2.80 (q, J = 6.8 Hz, 2H), 2.71 (q, J = 6.0 Hz, 1H), 2.45 (m,
2H), 2.40 (s, 3H). 13C NMR (methanol-d4, 100 MHz, 25˚C): d 152.39, 152.09, 146.59, 142.86,
133.97, 131.66, 130.80, 130.43, 123.77, 123.73, 74.42, 63.66, 57.95, 36.28, 35.05, 21.45. IR (neat,
ATR): 3345, 3286, 3024, 2922, 2855, 1601, 1581, 1497, 1451, 1416, 1302, 1154, 1050, 1034, 1012,
965, 849, 827, 712, 643, 617, 558. HRMS (ESI+): m/z calcd. for [C20H26N3O2]
+: 340.2020, found:
340.2022 ([M + H]+). Melting point: 141˚C.
Synthesis of N-((2S,3R,E) 1,3-dihydroxy-7-(4-(p-tolyldiazenyl) phenyl)hept-4-
en-2-yl)pentadec-14-ynamide (caCer-4)
aSph-2 (15.0 mg, 0.0442 mmol, 1.0 equiv.) and pentadec-14-ynoic acid (10.5 mg, 0.0442 mmol, 1.0
equiv.) were dissolved in CH2Cl2 (1.5 mL) and the solution was cooled to 0˚C with an ice bath. Diiso-
propylethylamine (23.1 mL, 0.133 mmol, 3.0 equiv.), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (12.7 mg, 0.0663 mmol, 1.5 equiv.) and 1-hydroxybenzotriazole hydrate (11.5 mg,
0.0751 mmol, 1.7 equiv.) were added sequentially to the flask, and the mixture was allowed to warm
to room temperature and was stirred for 4 hr. TLC analysis indicated some aSph-2 remained, and
the mixture was cooled to 0˚C and additional pentadec-14-ynoic acid (5.2 mg, 0.022 mmol, 0.5
equiv.), diisopropylethylamine (7.7 mL, 0.044 mmol, 1.0 equiv.), 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimidehydrochloride (4.2 mg, 0.022 mmol, 0.5 equiv.) and 1-hydroxybenzotriazole hydrate
(3.4 mg, 0.22 mmol, 0.5 equiv.) were added. The mixture was left to stir at room temperature for 17
hr and saturated aqueous sodium bicarbonate solution (5 mL) was added. The aqueous layer was
separated and extracted with CH2Cl2 (3  5 mL). The combined organic layers were washed with 1
M hydrochloric acid (5 mL) and brine (5 mL), dried over anhydrous sodium sulfate, filtered and con-
centrated under reduced pressure. The residue was purified by flash column chromatography (80%
EtOAc in pentane) to afford caCer-4 (17.2 mg, 0.0307 mmol, 70%) as an orange solid.
TLC (80% EtOAc in pentane): Rf=0.30.
1H NMR (CDCl3, 400 MHz, 25˚C): d 7.82 (d, J = 8.4 Hz,
2H), 7.80 (d, J = 8.4 Hz, 2H), 7.31 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 6.20 (d, J = 7.6 Hz,
1H), 5.79 (dt, J = 14.0, 6.5 Hz, 1H), 5.52 (dd, J = 14.0, 6.2 Hz, 1H), 4.28 (t, J = 5.0 Hz, 1H), 3.85 (dq,
J = 7.5, 3.7 Hz, 1H), 3.79 (dd, J = 11.3, 3.9 Hz, 1H), 3.61 (dd, J = 11.3, 3.5 Hz, 1H), 2.79 (t, J = 7.5
Hz, 2H), 2.46 (m, 2H), 2.43 (s, 3H), 2.18 (m, 4H), 1.94 (t, J = 2.6 Hz, 1H), 1.61 (t, J = 7.3 Hz, 2H), 1.50
(q, J = 7.3 Hz, 2H), 1.43–1.33 (m, 2H), 1.30–1.22 (m, 16H). 13C NMR (CDCl3, 100 MHz, 25˚C): d
174.14, 151.32, 150.86, 144.70, 141.56, 132.33, 130.28, 129.86, 129.30, 122.90, 122.89, 84.97,
74.45, 68.19, 62.41, 54.56, 36.92, 35.35, 33.83, 29.73, 29.71, 29.63, 29.51, 29.42, 29.25, 28.90,
28.62, 25.88, 21.65, 18.53. IR (neat, ATR): 3294, 2920, 2850, 1643, 1603, 1542, 1467, 1377, 1279,
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1156, 1104, 1049, 1014, 960, 895, 840, 722. HRMS (ESI+): m/z calcd. for [C35H50N3O3]
+: 560.3847,
found: 560.3851 ([M + H]+). Melting point: 111˚C.
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